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palavras-chave 
 
Proteína 1 associada com a lâmina (LAP1), Membrana nuclear interna (INM), 
Mutação da Ataxia Telangiectasia (ATM), Factor 2 de ligação às repetições 
teloméricas (TRF2), Proteína 1 activadora repressora (RAP1), quebras de DNA 
de cadeia dupla (DSBs), Membro da família da histona 2A (γ-H2AX), Involucro 
nuclear (NE) 
 
Resumo 
 
 
Proteína 1 associada com a lâmina (LAP1) é uma proteína integral da membrana 
do tipo II localizada na membrana nuclear interna (INM). O papel da LAP1 não 
é inteiramente sabido, no entanto esta proteína tem sido associada a algumas 
funções celulares devido às suas interações com as lâminas, proteína fosfatase 
1 (PP1), emerina e torsinA. Além disso, novos putativos interactores da LAP1 
estão a surgir. Um  recente estudo do nosso grupo permitiu a identificação de 
vários novos putativos interactores da LAP1 envolvidos na sinalização dos 
telómeros e em respostas a danos no DNA, nomeadamente a mutação da ataxia 
telangiectasia (ATM), fator 2 de ligação às repetições teloméricas (TRF2), 
proteína 1 ativadora repressora (RAP1), fator homólogo 1 de interação com a 
RAP1 (RIF1), proteína 1 do checkpoint do fuso mitótico (MAD2L1) e a proteína 
de ligação à proteína 1 do checkpoint do fuso mitótico (MAD2L1BP). As 
interações proteína-proteína são cruciais no estudo das vias de sinalização. 
Neste estudo, a TRF2 foi identificada como uma nova proteína interatora da 
LAP1 utilizando tanto co-immunoprecipitação como metodologias baseadas em 
espectrometria de massa. Para determinar a relevância funcional do novo 
complexo LAP1:TRF2, células HeLa foram submetidas a danos no DNA através 
do peróxido de hidrogénio (H202), nomeadamente a quebras de DNA de cadeia 
dupla (DSBs). Em resposta a DSBs, os níveis de expressão da LAP1 e da TRF2 
estavam significativamente reduzidos. A fosforilação do membro da família da 
histona 2A (γ-H2AX) que é considerado um biomarcador de DSBs foi também 
avaliada. Em resposta a danos no DNA, a LAP1 não só co-localiza com a γ-
H2AX em alguns pontos específicos perto do invólucro nuclear (EN) e núcleo, 
mas também com TRF2 na periferia nuclear. Além disso, a LAP1 e a TRF2 têm 
sido reportadas como proteínas cruciais na progressão do ciclo celular. Por isso, 
decidimos prosseguir com esta questão. Quando o EN é remontado, o complexo 
está localizado principalmente em regiões especificas do EN, evidenciado que 
a TRF2 permite a ligação dos cromossomas à membrana do NE em células 
somáticas. Como conclusão, os nossos resultados são de uma importância 
suprema, uma vez que novas descobertas funcionais relativas ao novo 
complexo LAP1:TRF2 foram alcançadas, particularmente relacionadas com 
respostas a danos no DNA e progressão do ciclo celular. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
keywords 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lamin associated protein 1 (LAP1), Inner nuclear membrane (INM), Ataxia-
telangiectasia mutated (ATM), Telomeric repeat binding factor 2 (TRF2), 
Repressor Activator Protein 1 (RAP1), Double-stranded breaks (DSBs), Histone 
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abstract 
 
 
Lamin associated protein 1 (LAP1) is a type II integral membrane protein located 
at the inner nuclear membrane (INM). The role of LAP1 remains poorly 
understand, however, this protein has been associated with several cellular 
functions due to its interactions with lamins, phosphatase protein 1 (PP1), emerin 
and torsinA. Moreover, novel putative LAP1 interactors are emerging. A recent 
study from our group allowed the identification of several novel putative LAP1 
interactors involved in telomere signaling and DNA damage responses, namely 
Ataxia-telangiectasia mutated (ATM), Telomeric repeat binding factor 2 (TRF2), 
Repressor Activator Protein 1 (RAP1), RAP1 interacting factor 1 homologue 
(RIF1), Mitotic arrest deficient-like1 (MAD2L1) and Mitotic arrest deficient-like1 
binding protein (MAD2L1BP). Protein-protein interactions are crucial in the study 
of signaling pathways. In this study, TRF2 was identified as a novel LAP1 binding 
protein using both co-immunoprecipitations and mass spectrometry based 
methodologies. To determine the functional relevance of the novel complex 
LAP1:TRF2, HeLa cells were subjected to DNA damage using hydrogen 
peroxide (H2O2), namely double-stranded breaks (DSBs). In response to DSBs, 
the expression levels of LAP1 and TRF2 were significantly reduced. The 
phosphorylation of Histone 2A family member (γ-H2AX) that is considered the 
hallmark of DSBs was also evaluated. Upon DNA damage, LAP1 not only co-
localizes with γ-H2AX in some specific points near nuclear envelope (NE) and 
nucleus, but also with TRF2 in the nuclear periphery. Moreover, LAP1 and TRF2 
have been reported to be crucial for cell cycle progression. Therefore, we 
decided to pursued this issue. When the NE is reassembled, the complex is 
located mainly in specific regions of the NE, evidencing that TRF2 allows the 
attachment of chromosomes to NE membrane in somatic cells. In conclusion, 
our results are of paramount importance since novel functional insights regarding 
the novel LAP1:TRF2 complex were achieved particularly related with DNA 
damage response and cell cycle progression. 
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1. Introduction  
1.1 Organization of the Nuclear Envelope  
The nuclear envelope (NE) is a highly organized double membrane that separates the 
nucleus from the cytoplasm in eukaryotic cells. It is constituted by the outer (ONM) and the 
inner nuclear membranes (INM) that are interconnected through nuclear pore complexes 
(NPCs) and nuclear lamins (Figure 1). The NPCs regulate the passage of macromolecules 
between the nucleus and cytoplasm and are associated with the nuclear laminas1. The ONM 
is coated with ribosomes and it is continuous with the endoplasmic reticulum (ER), while 
the INM is constituted by membrane proteins and phospholipids, and it is closely associated 
with chromatin (Figure 1). The INM and the ONM are separated by a perinuclear space 
(PNS) and are functionally unique due to enrichment of distinct integral membrane 
proteins2,3 (Figure 1). The nuclear lamina is a meshwork of intermediate filaments 
juxtaposed to the INM and is composed by lamins4. Lamins are type-V intermediate filament 
proteins5. The nuclear lamins are composed of A- and B-type lamins, which play important 
roles in nuclear stability, chromatin function and gene expression6. There are three genes 
encoding nuclear lamins, LMNA, LMNB1 and LMNB2. The LMNA gene encode for A-type 
lamins, while the LMNB1 and LMNB2 encode for B-type lamins (lamin B1, B2, and B3). A-
type lamins are expressed in a specific tissue manner during differentiation, while the B-type 
lamins are expressed in all cell types7. 
 
Figure 1. Structure of NE. The NE is a highly complex organelle composed by a double membrane 
which separates the nucleus from cytoplasm. The NE is constituted by the INM, ONM, nuclear lamins and 
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NPCs. The INM and ONM is separated by PNS. The ONM is continuous with ER and it is coated with 
ribosomes. The INM maintains interactions with chromatin and it is constituted by membrane proteins. The 
nuclear lamins are intermediate filaments located in INM and are constituted by lamin proteins. The NPCs 
regulate the passage of macromolecules between the nucleus and the cytoplasm. Adapted from2. 
 
1.1.1 Nuclear envelope proteins 
 The NE proteins can be classified according to their position in the NE. The first 
group is constituted by trans-nuclear membrane proteins in the NPCs, the second group is 
characterized by integral nuclear membrane proteins that are localized in the INM through 
transmembrane domains and stabilizing interactions with lamins and chromatin (for 
example, Lamin B Receptor (LBR), Lamina Associated Polypeptide 1 (LAP1), Lamina 
Associated Polypeptide 2 (LAP2), emerin, SUN and MAN1)) and finally, the third group is 
constituted by proteins which are located in the ONM, for instance, nuclear envelope spectrin 
repeat (nesprin)-1, -2, -3 and 46,8 (Figure 2). 
 The ONM and INM proteins are known to form complexes that bridge across the 
perinuclear space. These luminal proteinaceous bridges establish physical connections 
between the chromatin and cytoskeleton. They are therefore relevant in mechanisms as 
transcription, replication and deoxyribonucleic acid (DNA) repair6. 
 
 
 
Figure 2. NE proteins. NE proteins are classified according to their position in NE: i) NPCs proteins, 
ii) INM proteins (LBR, MAN1, SUN, LAP2, emerin, and LAP1) and iii) ONM proteins (nesprins). Reproduced 
from15. 
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1.1.1.1 Nuclear Pore Complexes 
The NPCs are protein complexes responsible for molecular trafficking between the 
nucleus and the cytoplasm of eukaryotic cells and they are embedded in the NE double- 
membrane. The NPCs have a cylindrical geometry and a molecular weight between 60 to 
100 MDa9,10. Structurally, the NPCs are constituted by cytoplasmic filaments, the central 
core and the nuclear basket (Figure 3). The central core is constituted by five concentric 
cylinders which are constituted by four substructures: pore membrane proteins (POMs), coat 
nucleoporins, adaptor nucleoporins, channel nucleoporins and phenylalanine-glycine (FG) 
repeats11 (Figure 3). 
 
 The NPCs are constituted by a set of 30 proteins termed nucleoporins or Nups. The 
Nups are composed by three structural units: α-helical regions, β-propellers and FG repeats 
that mediate nucleocytoplasmic transport of molecules that cross the NE12,11,13.  According 
to their localization within the NPCs, the Nups can be classified into six categories: i) integral 
membrane protein of the POMs domain, ii) membrane-apposed coat nucleoporins, iii) 
adaptor nucleoporins, iv) channel nucleoporins, v) nuclear basket nucleoporins and vi) 
cytoplasmic filament nucleoporins11. The Nups are essential for cell division, transcriptional 
Figure 3. Structure of NPCs. The NPCs are protein complexes constituted by cytoplasmic filaments 
(blue), the central core and the nuclear basket (purple). The central core has five substructures: pore membrane 
proteins (POMS), represented in green; coat nucleoporins, represented in yellow; adaptor nucleoporins, 
represented in red; channel nucleoporins, represented in orange and Phenylalanine-glycine (FG) repeats, 
represented in blue. Adapted from11. 
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activation and regulation of the protein and RNA transport between the nucleus and the 
cytoplasm14.  
 
1.1.1.2 Inner Nuclear Membrane  
The research into the INM is highly relevant for human health, since the INM is a 
structure enriched in proteins that are important for many cellular processes, including 
maintenance of the nuclear structure, chromosome organization, DNA repair and 
transcriptional control15,16. The LBR is an INM protein encoded by LBR gene that belongs 
to the sterol reductase family8 (Figure 4). It binds to emerin and heterochromatin protein 1 
(Hp1), through its NH2-terminal domain15,17. 
Emerin is a type II integral membrane protein encoded by EDM gene18 (Figure 4). 
Emerin is involved in multiple biological processes, such as direct and indirect regulation of 
transcription factors activity, nucleo-cytoskeletal mechanotransduction, maintenance of the 
nuclear structure, chromatin condensation and epigenetics modifications. This protein has 
the capacity to attenuate Wnt signaling, since it binds to β-catenin and inhibits its nuclear 
accumulation, influencing thereby adipogenesis. Furthermore, emerin binds to and inhibits 
Lmo7 transcription factor that is expressed at high levels in the muscle and heart tissues, 
regulating a variety of muscle-related genes19, 20.  
 MAN1 is a protein constituted by two transmembrane spanning domains, the NH2- 
and the COOH-terminal nucleoplasmic domains21,22 (Figure 4). This protein plays a 
fundamental role in chromosome segregation, cell division and early development. Several 
INM proteins together with MAN1 contribute to the nuclear assembly by re-associating with 
chromatin and facilitating the conversion of tubular ER into the sheet ER to reform the NE 
immediately after mitosis22,23. Furthermore, MAN1 shares a conserved globular domain with 
two INM proteins, namely LAP2 and emerin, designated as the LEM domain (LAP2, emerin, 
MAN1). This domain binds to lamins and play a role in tethering chromatin through BAF 
(barrier-to-autointegration factor). These mutual binding partners (LEM-domain proteins, 
lamins, BAF) are very important in the reassembly of the NE and lamin networks around 
chromatin after mitosis6,19,24,25. 
LAP1 is a type II integral membrane protein encoded by the TOR1AIP1 gene and 
interacts with lamins, torsinA, protein phosphatase 1 (PP1) and emerin, providing a pivotal 
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mechanism for transducing signal across the INM26 (Figure 4). A detailed description of this 
protein is available below (section 1.2). 
LAP2 is also a type II integral membrane that belongs to the thymopoietins family. 
This protein plays an important role in NE organization due to its binding to lamins and 
chromosomes. LAP2 is additionally involved  in the association between chromosome- 
membranes27,28 (Figure 4). 
SUN-domain proteins (SUN 1 and SUN 2) together with nesprins form the LINC 
complex (Linker of Nucleoskeleton and Cytoskeleton). The SUN proteins link the nuclear 
lamina with the actin and tubulin cytoskeleton and play a role in nuclear positioning and 
cellular migration29 (Figure 2). 
 
 
1.1.1.3 Outer Nuclear Membrane  
 Nesprins are vertebrate spectrin-repeat (SR)-containing proteins and are localized in 
ONM. These proteins are composed by a conserved C-terminal Klarsicht/ANC-1/Syne 
Homology (KASH) domain and are key components of the LINC complex30.  
 In the cytoplasm, nesprins bind to cytoskeletal elements and they are projected into 
the PNS, where they interact with INM proteins termed SUN proteins. The LINC complex 
is involved in many cellular functions, including nuclear positioning, mechanotransduction, 
cell division, organization of the cytoskeleton, polarity/migration, cell signaling, cell 
stiffness, nuclear migration, organelle positioning, ciliogenesis, meiosis, chromatin 
Figure 4. Schematic view of the INM proteins. The inner nuclear membrane is a structure enriched 
with membrane proteins that are crucial for many biological processes. LBR binds to emerin and chromatin 
associated proteins, like HP1. The LEM domain-containing proteins (LAP2, emerin, MAN1) are known to 
bind to chromatin associated proteins, like the barrier autointegration factor (BAF). Sun proteins interact 
through the PNS with nesprins and together forms the LINC complex. LAP1 interacts with lamins, torsinA, 
PP1 and emerin while LAP2 binds to lamins and chromosomes. Reproduced from36. 
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organization, chromosome movement, cell/nuclear architecture and DNA damage 
repair20,30,31. 
  In mammals, four KASH-domain proteins were identified, including nesprin-1, -2, -
3 and -4. The nesprins-1 and -2 are known to stabilize connections with the actin 
cytoskeleton and co-localize with LAP1, emerin and lamins at the NE30,32,33. Nesprins-3 
binds to plectin, a protein that is associated with a filaments system: actin filaments, 
intermediate filaments and microtubules34. Nesprin-4 is present in the NE of the salivary 
gland, exocrine pancreas, bulbourethral gland and mammary tissue35. 
1.2 Lamina Associated Polypeptide 1  
 
1.2.1 Physiological role of LAP1 
As mentioned above, LAP1 is a type II integral membrane protein located in INM. 
LAP1 is encoded by the TOR1AIP1 gene. Members of the LAP1 family were identified 
using a monoclonal antibody against lamina-enriched fractions of rat liver nuclei. The 
antibody recognized three polypeptides in rat liver NEs, LAP1A (75 kDa), LAP1B (68 kDa) 
and LAP1C (56 kDa). These three LAP1 isoforms result from alternative splicing of the 
TOR1AIP1 gene26,36,37. Afterward, the same isoforms were described in mouse27. In humans, 
the full-length cDNA of LAP1B was isolated from an expression library of HeLa cells. 
Additionally, a splice variant of LAP1B was identified, which differs from the previously 
identified LAP1B by the delection of three nucleotides (CAG) from exon 3, resulting in the 
removal of one alanine in the LAP1B protein38. Recently, a new LAP1 isoform was 
identified in humans and was named LAP1C. LAP1C is abundant in both human cell lines 
and in tissues38. Briefly, the expression of both LAP1B and LAP1C isoforms is tissue 
specific, in testis and ovary have a similar expression, but in tissues like lung, kidney and 
spleen LAP1C is more abundant. Moreover, in brain and heart the expression of human 
LAP1B was higher than LAP1C27,38.  
Structurally, both LAP1B and LAP1C have a nucleoplasmic N-terminal domain, a 
single transmembrane (TM) domain and a luminal C-terminal domain that is located at the 
PNS. However, LAP1C has putatively a truncated N-terminal domain26,38.  
To date the precise physiological function of LAP1 is unknown, however several 
functions have been ascribed to LAP1 since it binds to several proteins. Among them are 
lamins, PP1, torsinA and emerin. LAP1 binds directly to lamin A/C and lamin B39. During 
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interphase and mitosis the LAP1 is associated with the maintenance of the NE architecture 
through its binding to lamins and chromatin38, 40 (Figure 5). LAP1B is a novel PP1 binding 
protein and it was established in our group that LAP1 is a novel PP1 substrate, with PP1 
dephosphorylating LAP1’s Ser306 and Ser31037,38. LAP1 also interacts with torsinA (Figure 
5), a protein with 332 amino acids that belongs to the AAA-ATPase (ATPase Associated 
with a variety of cellular Activities) family of chaperones. This interaction it is important for 
NE localization of torsinA, regulation of torsinA ATPase activity and NE dynamics41–43. 
Emerin was also identified as a LAP1 interacting protein. The interaction between these two 
proteins is mediated by LAP1 nucleoplasmic domain and it is relevant to NE integrity 
maintenance and skeletal muscle maintenance44.  
The protein phosphorylation is an important mechanism that regulates the cell cycle 
progression40 (Figure 5). During the mitosis, LAP1 is phosphorylated by several kinases that 
regulate the cell cycle, respectively on Ser143 by cyclin-dependent kinase (CDK) and on 
Ser164 by ataxia-telangiectasia mutated (ATM) and ataxia-telangiectasia and Rad 3-related 
(ATR)40. LAP1 is a protein that has a key role in the cell cycle progression and in the 
maintenance of the NE. During mitosis, in organisms such as yeast, the NE remains intact 
while in other organisms, such as Caenorhabditis elegans and Drosophila melanogaster, it 
is disrupted at later stages of mitosis40. In eukaryotes, the NE is completely disassembled at 
the beginning of mitosis and reassembled at the culmination of mitosis. The NE 
disassembled is characterized by disassembly of NPCs, depolymerization of lamins and 
spreading of NE soluble components and INM proteins to the cytoplasm and ER, while NE 
reassembly is characterized by an increase of INM proteins and lamins on the decondensing 
chromatin, lamin polymerization and NPCs assembly40. One of the first INM proteins 
identified was LAP140. During mitosis, LAP1 is associated to reassembly of NE, assembly 
of the mitotic spindle and co-localizes with α-tubulin and γ- tubulin, markers of microtubules 
stability and microtubule organizing center respectively. In interphasic cells, LAP1 appears 
to be associated with lamins and chromosomes in the INM. In prometaphase, LAP1 loses its 
association with lamins and chromosomes and it is found redistributed in ER, contributing 
to the NE breakdown. In anaphase, LAP1 is located at the chromosomes surface, the mid-
body (telophase) and the mitotic vesicles associated with the mitotic spindle38, 40.  
 A recent bioinformatics study from our laboratory described the LAP1 interactome. 
Briefly, 41 LAP1 interactors were identified, among them are RAP1 interacting factor 1 
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(RIF1), ATM, MAD2 mitotic arrest deficient-like 1 (MAD2L1), MAD2 mitotic arrest 
deficient-like 1 binding protein (MAD2L1BP), Telomeric repeat binding factor 2 (TRF2) 
and repressor activator protein 1 (RAP1), also known by Telomeric repeat binding factor 2 
interacting protein (TRF2IP). This study suggested several novel LAP1 putative functions, 
in addition to those already associated with LAP1, namely as regulation of response to DNA 
damage, nuclear membrane organization, nuclear envelope organization, cell cycle 
regulation, chaperone-mediated protein folding, nucleus organization, telomere 
maintenance, cellular component organization, telomere organization and cellular 
component disassembly involved in execution phase of apoptosis45. 
 
 
Figure 5. Functions of LAP1. The function of LAP1 protein is not completely known, some studies 
have been reported that: i) LAP1 plays an important role in maintenance of NE through its binding to lamins, 
ii) LAP1 binds to a torsinA protein that belongs to chaperone family, iii) LAP1 regulates the cell cycle and 
mitosis and during the mitosis it is dispersed at ER membranes (prometaphase), it is located at chromosomes 
surface (anaphase), the mid-body (telophase) and the mitotic vesicles associated with the mitotic spindle, and 
iv) LAP1 is also involved in telomere-association and DNA damage response. Reproduced from45 
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1.2.2 Pathological role of LAP1 
 To date were described four mutations in TOR1AIP1 gene. The first mutation was 
reported in a consanguineous Turkish family (“Turkish” mutation). This mutation consists 
of a homozygous G deletion at position c.186 (c.186delG) in TOR1AIP1 gene. The 
c.186delG mutation is a nucleotide delection in the first exon that is predicted to cause a 
frameshift and premature stop codon that subsequently results in the absence of LAP1B. 
This mutation leads to muscular dystrophy, a hereditary muscle disorder characterized by 
progressive muscular degeneration and weakness26,44,46. A second TOR1AIP1 mutation 
results from a homozygous missense mutation (c.1448A>C) and was reported in a boy born 
from consanguineous healthy parents (‘Moroccan’ mutation). This mutation results in a 
change of a glutamic acid to alanine at amino acid position 482, leading to a reduced 
expression levels of LAP1 at the NE. This reduction of LAP1 at the NE was observed with 
a concomitant mislocation and aggregation of LAP1 at the ER. These patients have rapidly 
progressing dystonia, progressive cerebellar atrophy and dilated cardiomyopathy26,47. More 
recently, two novel pathogenic TOR1AIP1 mutations have been reported in Australian 
family (“Australian” mutation). One is a frameshift mutation in exon 1 (c.127delC) of 
TOR1AIP1 gene which results in a truncated protein of 58 amino acids lacking the TM 
domain. Consequently, these patients do not express LAP1B. The last described mutation is 
a missense change in exon 10 (c.1181T>C, p. L394P). Both mutations cause severe cardiac 
failure, musculoskeletal weakness and muscular dystrophy48.  
Additionally, LAP1 appears to be implicated in DYT1 dystonia due to its binding 
with torsinA. TorsinA is a member of a family of ATPase AAA+ proteins localized to the 
lumen of the ER. A mutation (a glutamic acid (GAG) deletion in the 3’ coding region) in 
TOR1A gene that encodes for torsinA cause DYT1 dystonia, a movement disorder 
characterized by prolonged involuntary twitching movements45. This disease usually begins 
in childhood or adolescence and the symptoms start in the limbs with progression to other 
parts of the body. In normal conditions this protein is concentrated in PNS and rough 
endoplasmic reticulum (RER), while mutated the form is localized in PNS37,45,46. In NE, 
LAP1 interacts with torsinA and several evidences suggests that both proteins might have a 
combined crititical role at the NE dynamics45,46.   
As previously reported, LAP1 interacts with INM protein emerin, a protein that is 
associated with a neuromuscular disorder, called X-linked Emery-Dreifuss muscular 
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dystrophy (EDMD).  This neuromuscular disorder is characterized by: 1) early contractures 
of the elbows, Achilles tendons and postcervical muscles, 2) slowly progressive muscle 
wasting and weakness, 3) cardiomyopathy with heart block18,50–52.  
 
1.3 DNA Damage Response  
 In the human body, 1013 cells per day are subjected to thousands of DNA lesions that 
are capable of blocking genome replication, transcription and can originate mutations or 
genomic aberrations. These lesions threaten the cell and/or organism viability if they are not 
repaired or if they are repaired incorrectly53. To repair DNA damage the cells have developed 
a sophisticated mechanism known as DNA damage response54. DNA damage signaling and 
repair machinery’s main role is the maintenance of the genome integrity, which counteract 
the adverse consequences of DNA lesions and prevent their transmission to daughter cells55.  
 The DNA damage response involves a set of tightly regulated steps that start with 
the initial detection of DNA damage, recruitment of DNA repair factors to the damage site 
and the repair of DNA lesions. This pathway is highly controlled by post-translational 
modifications (PTM), namely phosphorylation, ubiquitination, sumoylation, methylation, 
acetylation and others56.  
 Protein phosphorylation is a well-characterized PTM mechanism associated with 
DNA damage response which involves the activity of proteins kinases. The 
phosphatidylinositol 3-kinase-related kinases (PIKKs), known as the heart of the DNA 
damage signaling cascade, are a family of serine/threonine proteins kinases, which include 
ATM, ATR and DNA-dependent protein kinase catalytic subunit (DNA-PKcs)56,57. The 
DNA damage response is mediated by proteins of PIKKs family (ATM, ATR and DNA-
PKcs) and by members of the poly (ADP) ribose polymerase (PARP) family58. The ATM 
protein kinase is a 3056-amino acid polypeptide that phosphorylates its substrates in 
response to double-stranded breaks (DSBs). Structurally, ATM is constituted by a FAT 
domain (conserved among members of PIKK family, FRAP, ATR ad TRRAP), which it is 
located between amino acids 1966 and 2565, a phosphoinositide 3, 4-kinase (PI3K) domain, 
which it is located between amino acids 2609 and 2976, and FAT carboxy-terminal (FAT-
C) domain, which it is located between amino acids 3024 and 3056. The amino terminal of 
ATM kinase (2659 amino acids) is constituted by HEAT repeats that are responsible for the 
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formation of a massive alpha helical scaffold57 (Figure 6). ATM is activated upon 
phosphorylation of serine 1981, represented by the P in the amino-terminal region of the 
FAT domain. This kinase is cleaved by caspase-3 in two sites (identified by arrows in Figure 
6), between amino acids 814-818 and between amino acids 860-86457. The ATR kinase 
possesses ssDNA or ssDNA/dsDNA junction DNA affinity, promoting several DNA 
metabolic processes that allow maintenance of the genomic integrity, namely replication 
fork stabilization, DNA synthesis and lesion bypass, HR, replication origin firing and cell 
cycle delay54,59. PARP1 and PARP2 are two members of PARP family involved in the DNA 
damage response, that are activated by SSBs and DSBs58.  
 
Figure 6. Structure of ATM kinase. The ATM is serine/threonine kinase constituted by 3056 amino 
acids. Structurally, it is constituted by: i) FAT domain is located between the amino acids 1966 and 2565, ii) 
PI3K domain is located between the amino acids 2609 and 2976 and iii) FAT-C domain is located between 
amino acids 3024 and 3056. The amino terminal composed by 2659 amino acids is constituted by HEAT 
repeats, this structure forms a massive alpha helical scaffold. ATM is activated by phosphorylation in serine 
1981, indicated by the P in the amino-terminal region of the FAT domain. The two arrows indicate the position 
of caspase-3 cleavage between amino acids 814-818 and 860-864. The star indicates a putative zipper region 
between amino acids 1216 and 1241. Adapted from57.  
 
1.3.1 ATM-mediated DNA Damage Response 
 When cells are exposed to damaging agents (cellular metabolism, oxidative stress, 
Ultraviolet radiation (UR), Ionizing Radiation (IR) and replication errors), DSBs are 
originated. The DSBs can be lethal to the cell, so it is very important to cell vitality that these 
lesions are detected early on58,60. Primarily, DSBs are sensed by a protein complex termed, 
the MRE11-RAD50-NBS1 (MRN) complex (Figure 7)57,61. The MRN complex is a DNA 
damage response sensor, which is responsible for recruiting ATM kinase, activation of cell 
cycle checkpoints, effector pathways and facilitating interplay between repair mechanisms. 
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Mre11 binds to Nbs1, DNA and Rad50. ATM kinase phosphorylates Nbs1 at Ser343 and 
both Nbs1 and MRN complex are vital to full activation of ATM57,61. Furthermore, the ATM 
kinase is also auto phosphorylated at Ser1981 and consequently the inactive dimer is 
converted into its active monomeric form in response to DSBs57,61 (Figure 7). The activation 
of ATM leads to phosphorylation and recruitment of downstream substrates, including breast 
and ovarian cancer locus 1 (BRCA1), p53-binding protein 1 (53BP1), histone 2A family 
member (H2AX), p53, Checkpoint kinase 2 (CHK2), Fanconi anemia complementation 
group D2 (FANCD2), structural maintenance of chromosomes protein 1A (SMC1) and 
Bloom’s syndrome mutated 1 (BLM1)62. 53BP1 also sustains the DNA damage signaling 
through ATM activation63 (Figure 7). BRAC1 is recruited to sites of DNA damage where it 
acts as a scaffold for ATM kinase activation and is involved in cell repair57,63 (Figure 7). In 
response to DSBs, γ-H2AX is phosphorylated at Ser139 by ATM and it can recruit the 
mediator of DNA damage checkpoint protein 1 (MDC1), which in turn leads to cell repair 
and chromatin descondensation (Figure 7). γ-H2AX is dephosphorylated by protein 
phosphatase 2A (PP2A) and this mechanism facilitates DSBs repair64. The activation of 
ATM kinase also leads to phosphorylation of downstream effectors, namely the Thr68 of 
Chk2 kinase. The Chk2 phosphorylates the central suppressor p53, which activates the 
transcription of genes that participate in DNA repair, senescence,  apoptosis and initiate cell 
cycle arrest at the G1-S boundary56 (Figure 7). The tumor suppressor protein p53 is a sensor 
of cellular stress and it is involved in the regulation of cellular responses to DNA damage65. 
p53 is phosphorylated by ATM at Ser15, and this phosphorylation leads to two mechanisms: 
i) cell growth arrest for repair DNA damage; or ii) apoptosis if the cells cannot be capable 
of repair DNA damage65,66 (Figure 7). 
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Figure 7. ATM kinase pathway. When the cells are exposed to damaging agents, for example, 
cellular metabolism, oxidative stress, UR, IR and replication errors, DSBs are originated. The DSBs are sensed 
by MRN complex. Mre11 binds to Nbs1, DNA and Rad50 and ATM phosphorylates Nbs1 at Ser343. MRN 
complex and Nbs1 are vital to full activation of ATM. The ATM kinase is auto phosphorylated at Ser1981 and 
consequently its inactive dimer is converted into an active monomeric form in response do DSBs. The ATM 
kinase phosphorylates several downstream subtracts, namely BRAC1, 53BP1, γ-H2AX, p53, CHK2, 
FANCD2, SMC1 and BLM1. 53BP1 sustains the DNA damage signaling through ATM activation. The 
BRAC1, γ-H2AX and BLM1 are responsible for DSBs repair, p53 and Chk2 leads to apoptosis, while 
FANCD2, SMC1 and p53 activate cell growth arrest. Adapted from57,62. 
 
1.4 Telomeres  
1.4.1 Biology of telomeres 
 The telomeres are specialized DNA structures constituted by TTAGGG repeat 
sequences located at the ends of chromosomes67,68. Telomeres protect the chromosomal ends 
from fusion and degradation. Furthermore, they prevent the chromosomes from being 
accidently recognized as sites of DNA damage by the DNA damage-repair system. Therefore 
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the telomeres serve as protective caps of chromosomes and they are crucial for the 
maintenance of genome integrity68,69.  
 Structurally, the telomeres of mammalian cells are constituted by telomere DNA, 
containing double-stranded tandem repeats of TTAGGG followed by terminal 3’ G-rich 
single-stranded overhangs. Telomere DNA adopt T-loop structure when the telomere end 
folds back on itself and 3’ G strand overhang invade into the double-stranded DNA 
(dsDNA), called D-loop70 (Figure 8). 
 
  
The telomeres homeostasis is essential to genome stability, cell survival and 
growth71. At each cell division the telomeres lose 30-150 base pairs72. The telomerase, a 
ribonucleoprotein complex, is responsible for maintaining the length of telomeres, 
preserving healthy cell function and long-term immune function67,72. This complex is 
composed by RNA and proteins components: two copies of telomerase reverse transcriptase 
(TERT), two copies of its integral RNA template (TERC) and dyskerin protein that binds to 
TERC and TERT increasing the stability of this complex69,73 (Figure 9). The TERT is 
required for the synthesis of new telomeric DNA repeats while the TERC serves as template 
for syntheses of telomeric DNA72,74.  
Figure 8. Structure of mammalian telomeres. The telomeres are DNA structures constituted by a 
set of repetitive nucleotides sequences (TTAGGG). Structurally, the telomeres are composed by: i) double-
stranded tandem repeats of TTAGGG, ii) 3’ G-rich single-stranded overhang, iii) T-loop and iv) D-loop. 
Adapted from75. 
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The shelterin complex is a complex comprised by six proteins, which is crucial for 
both the maintenance of telomere structure and its signaling functions telomeres, namely 
Telomeric repeat binding factor 1 (TRF1), TRF2, RAP1, TRF1 interacting nuclear factor 2 
(TIN2), tripeptidyl peptidase 1 (TPP1) and protein protection of telomeres 1 (POT1). TRF1 
and TRF2 bind directly to the TTAGGG sequences in double-stranded segment of telomeric 
DNA72,75 (Figure 10). POT1 binds directly to the same sequences in single-stranded form 
(single-stranded DNA (ssDNA)), and it is crucial to the formation of the D-loop when it 
binds to the 3’ overhang and interacts with TPP167,72,75 (Figure 9). Rap1, also known as 
TRF2IP, interacts directly with TRF2 (Figure 10). TIN2 has important complex interactions 
with TRF1, TRF2 and TPP169 (Figure 10). Finally, TIN2 and TPP1 are key components that 
mediate the activity of the shelterin complex 76.  
 TRF1 and TRF2 are different elements regarding their function in the shelterin 
complex. TRF1 has a crucial role telomeres length, while TRF2 prevents the telomere ends 
from being recognized as DSBs and it is involved in T-loop formation77. Regarding shelterin 
complex proteins, a detailed description of TRF2 and RAP1 is available below, given their 
importance for this thesis in particular. 
Figure 9. Structure of telomerase complex. The telomerase is a ribonucleoprotein complex 
responsible to maintain and preserves healthy cell function and long-term immune function by maintaining the 
length of telomeres. This complex is constituted by: i) two copies of telomerase reverse transcriptase (TERT), 
a fundamental structure for the syntheses of new telomeric DNA repeats ii) two copies of its integral RNA 
template (TERC), a structure that serves as template for telomeric DNA syntheses and iii) dyskerin protein, a 
protein that binds to TERT and TERC and increases the stability of this complex. Reproduced from69. 
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1.4.1.1 TRF2 
 TRF2 is a protein encoded by the TERF2 gene and it is responsible for preventing 
mammalian telomeres from activating DNA damage checkpoints and regulates T-loop 
formation, as previously mentioned76. TRF2 is an ubiquitous protein that is present at more 
than 100 copies per chromosome end and it is essential for protection of all chromosomes in 
all steps of cell cycle78. Structurally, the TRF2 is composed by four domains: a C-terminal 
Myb Domain that binds to double-stranded telomeric DNA (TTAGGG); a flexible Hinge 
domain that is involved in protein-protein interactions; a TRFH domain necessary for 
homodimerization and a divergent N-terminal domain, which is rich in basic residues (basic 
domain) (Figure 11). The TRFH domain is required to prevent the first steps of the DNA 
damage response pathway. The Hinge domain promotes the interaction between TRF2 and 
two members of shelterin complex involved at the protection of end chromosomes, namely 
TIN2 and Rap179. 
 
Figure 10. The Shelterin complex. The mammalian telomeres are composed by a protein complex 
that regulates the structure of telomeres and protects the chromosome from enzymatic attack, the Shelterin 
complex. This complex is constituted by six proteins: i) TRF1 that binds to the TTAGGG sequences in double-
stranded segments of telomeric DNA and regulates the length of telomeres; ii) TRF2 that also binds to the 
TTAGGG sequences in double-stranded segment of telomeric DNA, regulates the T-loop formation and 
protects the telomeres ends from being mistaken as broken DNA; iii) RAP1 also known to TRF2IP that forms 
a complex with TRF2; iv) TIN2 that stabilizes interactions between TRF1, TRF2 and TPP1; v) POT1 that 
binds to the TTAGGG sequences in single-stranded form and to TPP1 in order to form the D-loop; vi) TPP1 
forms an important complex that allow cells to distinguish telomeres from sites of DNA damage with the TIN2 
and RAP1. Adapted from75. 
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Figure 11. Structure of TRF2 protein. TRF2 is composed of four domains: i) a C-terminal Myb 
Domain that binds to double-stranded telomeric DNA (TTAGGG); ii) a flexible Hinge domain that is involved 
in protein-protein interactions; iii) a TRFH domain necessary for homodimerization and iv) a divergent N-
terminal domain rich in basic residues (basic domain). Adapted from79.  
 
1.4.1.2 RAP1 
RAP1 is a protein that belongs to the shelterin complex, known to stabilize the 
interaction with TRF277. Recently, it was demonstrate that RAP1 binds to TTAGGG 
telomeric repeats through its interaction with TRF2 and also binds (directly) to chromosome 
arms where it establishes a vital function, regulation of gene expression80. Structurally, 
RAP1 is constituted by four domains: a N-terminal BRCT domain; a Myb domain; a coiled-
coil domain and a C-terminal TRF2-binding RAP1 C-terminal (RCT) domain (Figure 13). 
The RCT domain binds to the RBM (RAP1 binding motif ) domain of TRF2 forming a 
multifunctional complex, called RAP1/TRF2 complex81. The N-terminal BRCT domain 
binds to a phosphorylated target protein when dimerized in the shelterin complex, while the 
C- terminal serves to anchor the protein in shelterin complex82.  
 
  
  
Figure 12 RAP1 proteins structure. RAP1 protein is constituted by four domains: i) N-terminal 
BRCT domain that binds a phosphorylated target protein when dimerized in the Shelterin complex; ii) Myb 
domain; iii) coiled- coil domain and iv) RCT domain that binds to RBM domain of TRF2 protein.  Adapted 
from81. 
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1.4.1.3 Expression of TRF2/RAP1 proteins upon DNA damage 
Recently, some proteins that play important roles in DNA repair have also been 
associated to telomere maintenance. Members of PIKKs family, such as ATM and DNA-
PKcs are involved in the maintenance of genomic stability via DNA repair pathways. These 
members appear also appear to be involved in telomere maintenance83. The mechanisms of 
communication between these two major cellular processes have intensified84. The telomeres 
act as protective caps to prevent chromosome ends from being recognized as DSBs, as 
previously reported. When telomeres become dysfunctional, chromosomes ends activate a 
DNA damage response mediated by ATM84,85. When ATM kinase is activated, the 
chromosome ends become associated with DNA damage response factors, such as 53BP1, 
γ-H2AX, and the MRN complex83. The mechanism by which telomeres prevent these events 
has been investigated85. TRF2 inhibits autophosphorylation of ATM kinase on Ser 1981 at 
telomeres and it is required to prevent mammalian telomeres from activating DNA damage 
checkpoints83.  
RAP1 forms a multifunctional complex with TRF2. This complex stabilizes 
interactions with a set of key proteins in the DNA damage pathway, namely ATM, MRN 
complex, Ku, DNA-PKcs, WRN (Werner syndrome protein), BLM and cooperates in 
functions of DNA repair77,86. TRF2 associates the telomeres to proteins involved in DSB 
repair. TRF2 has also been associated with a new non-telomeric function, namely in DNA 
repair response mechanisms. This protein has an intrinsic ability to interact with DSBs and, 
in response to DNA damage, it is phosphorylated by ATM migrating rapidly to specific sites 
of DNA damage caused by DSBs (laser microbeam irradiation)84,87. The phosphorylated 
form of TRF2 is involved in telomere DNA repair by recruitment of additional DNA repair 
proteins to damaged telomeric DNA, playing a crucial role in DNA damage signaling 
responses. However, the exact role of TRF2 during DNA damage response remains to be 
determined84.  
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2. Objectives 
 LAP1 is a type II transmembrane protein encoded by the TOR1AIP1 gene and it is 
located at the INM. Several LAP1 functions have been described due to the identification of 
its binding partners. These binding partners include lamins, torsinA, emerin and PP1, which 
convey crucial cellular functions to LAP1 itself, namely in nuclear architecture maintenance 
and chromatin regulation (LAP1: lamins), regulation of torsinA ATPase activity, nuclear 
envelope localization of torsinA and NE dynamics (LAP1: torsinA), nuclear envelope 
integrity maintenance and skeletal muscle maintenance (LAP1: emerin), and regulation of 
cell cycle progression (LAP1: PP1). Furthermore, several novel putative LAP1 interactors 
are emerging. In fact, recent data from our group allowed the identification of several novel 
putative LAP1 functionally associated proteins, namely TRF2, RAP1, RIF1, ATM, 
MAD2L1 and MAD2L1BP. Some of these proteins are involved in DNA damage response 
and telomere signaling.  
 Therefore, the main objective of this thesis is to expand the knowledge of LAP1 in 
the DNA damage response and in cell cycle progression, through the study of two of its 
putative protein interactors, namely TRF2 and RAP1. 
 
The specific aims of this thesis are: 
 
 To establish TRF2 and RAP1 as novel LAP1 interactors; 
 
 To determine the expression levels of LAP1 and TRF2 during DNA damage 
induced by Hydrogen Peroxide (H202); 
 
 To evaluate the subcellular distribution of LAP1 and TRF2 during DNA damage; 
 
 To further access the subcellular distribution of LAP1 and TRF2 during cell cycle 
progression. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
_______________________
  
 
 
 
 
 
  
  
 
 
26 
 
 
3. Materials and Methods  
 
3.1 Cell Culture  
 The SH-SY5Y human neuroblastoma cell line is derived from the cell line SK-N-SH 
which was extracted from a bone marrow biopsy of a neuroblastoma patient. HeLa cells are 
an immortalized line cell derived from human cervical carcinoma. SH-SY5Y were 
maintained in Minimum Essential Media (MEM) supplemented with F-12 nutrient mixtures 
(Gibco), 10% fetal bovine serum (FBS; Gibco), 1.5 mM L-glutamine and 100 U/mL 
penicillin and 100 mg/mL streptomycin). HeLa cells were maintained in Dulbeco’s 
Minimum Essential Media (DMEM; Gibco) supplemented with 10% FBS (Gibco) and 1100 
U/mL penicillin and 100 mg/mL streptomycin. Culture medium was changed every other 
day and cells were subcultured when 90-95% confluence was reached. All the cultures were 
maintained in a 5% CO2 humidified incubator at 37ºC. 
 
3.2 Antibodies 
 To detect the proteins analyzed in the experimental procedures of this dissertation 
several primary antibodies were used, namely anti-LAP188, anti-RAP1 (Abcam), anti-TRF2 
(Abcam) and anti-γ-H2AX (Millipore). The selection of the secondary antibodies was 
achieved according to the specific technique used, namely, immunocytochemistry (ICC) and 
western blot (WB). For WB, the secondary goat antibodies with horseradish peroxidase 
(HRP) (GE Healthcare) were used to recognize mouse or rabbit primary antibodies. For ICC 
assays Alexa Fluor 488 goat-anti rabbit and Alexa Fluor 594 anti-mouse (Life Technologies) 
were used. Tables 1 and 2 summarize the multiple antibodies used and their respective 
dilutions. 
 
 
 
 
 
 
  
 
27 
 
Table 1 Summary of the primary antibodies used to detect target proteins and specific dilutions 
used for different assays. BSA, Bovine Serum Albumin; PBS, Phosphate-buffered saline solution; TBS-T, 
Tris-buffered saline-Tween; ICC, Immunocytochemistry; WB, Western Blot; Co-IP, Co-Immunoprecipitation. 
Primary 
Antibody 
Antibody 
type 
Target Dilution Blocking Solution 
 
Anti-LAP1 
 
 
Rabbit, 
polyclonal 
 
LAP1 
ICC 1:4000 3% BSA/ 1x PBS 
WB 1:20000 3% BSA/1x TBS-T 
Co-IP 0.2 µl per 2500 
µg protein 
 
 
Anti-RAP1 
Mouse, 
monoclonal 
(Abcam) 
 
RAP1 
WB 1:5000 3% BSA/1x TBS-T 
Co-IP 5µg per mL  
 
 
Anti-TRF2 
Mouse, 
monoclonal 
(Abcam) 
 
TRF2 
ICC 1:500 3% BSA/ 1x PBS 
WB 1:2000 3% BSA/1x TBS-T 
Co- IP 2 µg per 106 
cells 
 
 
Anti-γ-H2AX 
Ser 139 
Mouse, 
monoclonal 
(Millipore) 
γ- H2AX 
Ser139 
ICC 2 µg per mL 3% BSA/ 1x PBS 
WB 1:500 3 % BSA/ 1x TBS-T 
 
 
Table 2 Summary of the secondary antibodies used to detect target proteins and specific 
dilutions used for different assays. BSA, Bovine Serum Albumin; PBS, Phosphate-buffered saline solution; 
TBS-T, Tris-buffered saline-Tween; ICC, Immunocytochemistry; WB, Western Blot. 
Secondary 
Antibodies 
Antibody type 
Dilution Blocking Solution 
Alexa Fluor 
488 
Goat, anti-rabbit 
ICC 1:300 3% BSA/ 1x PBS 
Alexa Fluor 
594 
Goat, anti-mouse 
ICC 1:300 3% BSA/ 1x PBS 
α-ECL anti- 
mouse 
Goat, anti-mouse 
WB 1:5000 3% milk/ 1× TBS-T 
α-ECL anti- 
rabbit 
Goat, anti-rabbit 
WB 1:5000 3% milk/ 1× TBS-T 
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3.3 HeLa cells exposure to different concentrations of H202 
 Oxidative stress induces a variety of different types of DNA damage, including 
purine and pyrimidine damage, sugar moiety damage, SSBs and DSBs. Hydrogen Peroxide 
(H202) is one Reactive oxygen species (ROS) involved in many cellular functions, such as 
development, proliferation and differentiation. This molecule is involved in ATM activation, 
H2AX phosphorylation and DSBs generation57,89,90.  
 To induce DNA damage, HeLa cells were exposure to different concentrations of 
H202 (Acros Organic). Therefore, cells were plated in 12-well plates (Corning) with a cell 
density of 1.6x105 cells per well and incubated at 37ºC with 5% CO2 for 16 hours. Upon this 
period, cells were incubated with standard medium with deferential H202 concentrations: 20, 
40 and 80 µM of H202. In the control condition, no H202 was added. The different H202 
concentrations were prepared from a H202 stock solution (10 mM). Cells were incubated 
with H202 for 0, 6 and 12 hours. At those specific time points HeLa cells were trypsinzed 
and resuspended in culture medium and the cell viability determined, as described below. 
 
3.4 Cell Viability  
 HeLa cells growing curve upon H202 treatment, was determined using the trypan blue 
(TB) exclusion dye method. Trypan blue penetrates the membrane of dead cells which 
became colored in blue. In living cells the plasma membrane is intact and it is not permeable 
to TB, remaining uncolored. At all times points, 10 µl of trypan blue (Sigma) were added to 
90 µl of cell suspension and counted in duplicate in the hemocytometer. A cell viability 
curve was calculated based on these values and the data is represented with the mean ± SEM 
from at least 3 independent experiments performed in duplicate, adding up to 6 experiments 
in total. 
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3.5 Measurement of cell death  
Apoptotic cells show alterations in nuclear morphology. These alterations can be 
measured by the assessment of nuclear staining. Healthy cells show diffuse staining of the 
nucleus unlike the apoptotic cells. The alterations in nuclear morphology of apoptotic cells 
can be divided in three classes: i) chromatin condensation; ii) nuclear fragmentation and iii) 
nuclear condensation. The chromatin condensation is characterized by chromatin 
margination without nuclear condensation, the nuclear fragmentation is characterized by 
chromatin margination with nuclear condensation and nuclear condensation is characterized 
by a decreasing of nuclei size without chromatin margination91 (Figure 13). Measurement of 
cell death can be assessed by fluorescence microscopy using 4’, 6-diamidino-2-phenylindole 
(DAPI).  
To measure cell death, HeLa cells were plated in 12-well plates with a seeding 
density of 1.6x105 cells per well and incubated at 37ºC with 5% CO2 for 16 hours. After 16 
hours, cells were incubated with different concentrations of H202 (20, 40 and 80 µM of H202). 
The control condition with no addition H202 was also performed. In different times points 
(0, 6 and 12 hours), the cells were washed with 1x PBS and then fixed with 4% 
paraformaldehyde (PFA) for 20 minutes. After fixation, the cells were washed three times 
with 1mL of 1x PBS.  Then, the samples were mounted on a microscope slide with DAPI- 
containing VECTASHIELD® Mounting media (Vector Laboratories). The microscope 
slides were visualized in a fluorescent microscope, using the objective 20x in Olympus IX-
81 (Olympus, Optical Co. GmbH) motorized inverted microscope equipped with a PlanApo/ 
1.40 oil immersion objective lens. Photographs were obtained with a digital CCD 
monochrome camera F-view II (Soft Imaging System). The percentage of apoptotic cells 
was calculated in each condition.  
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Figure 13. Representative DAPI staining of healthy and apoptotic nucleus. A) Staining of normal 
nuclei, B) Chromatin condensation, C) Nuclear fragmentation and D) nuclear condensation. Reproduced 
from91. 
3.6 Proteomic Assays 
 
3.6.1 Cell collection and protein quantification 
 Cell’s conditioned media was centrifuged at 1000 rpm for 3 min, washed with 1x 
PBS and newly centrifuged. Following, the cells were resuspended in 100 µl (12 well) of 
1% SDS for WB. The cell lysates were boiled at 90ºC for 10 min, sonicated for 5 secs and 
stored at -20ºC.  
 To quantify the total protein content of cell lysates the Pierce’s bicinchoninic acid 
(BCA) protein assay kit (Thermo Scientific) was used. This assay is a detergent-compatible 
formulation based on BCA for calorimetric detection and quantification of total protein. The 
method is based in the reduction of Cu2+ to Cu+ by protein in an alkaline medium. Cu+ 
interacts with bicinchoninic acid which results in the formation of an intense purple-colored 
reaction product, a water-soluble complex that can be measured at 562 nm with increasing 
protein concentrations over a working range of 0.02-2 µg/µL.  The total reduction of Cu2+ 
to Cu+ is equivalent to protein concentration which is determined by comparison to standard 
samples, these were prepared through of bovine serum albumin (BSA)92 as described in table 
3.    
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Table 3. Standards preparation. BSA, Bovine Serum Albumin.  
Standards BSA (µL) Extraction Buffer 
(µL) 
Protein mass 
(µg) 
Concentration 
(µg/ µL) 
P0 0 25 0 0 
P1 1 24 2 0.08 
P2 2 23 4 0.16 
P3 5 20 10 0.4 
P4 10 15 20 0.8 
P5 20 5 40 1.6 
 
 
3.6.2 SDS-PAGE  
 The samples were separated on a sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE), a denaturing gel that allows the separation of proteins 
according to their molecular weight, followed by electrotransference of the immobilized 
proteins into a nitrocellulose membrane. The membranes will be further used for the 
immunological detection of the proteins of interest using specific antibodies. To analyze the 
co-immunoprecipitation experiments a 7.5% polyacrylamide gel was used (since TRF2, 
RAP1, LAP1B and LAP1C have molecular weights around 50 kDa and 75 kDa). To analyze 
the LAP1, γ-H2AX and TRF2 expression upon H202 treatment, a gradient gel (5-20%) was 
used.  
Prior to loading, the samples were prepared by the addition 1x loading buffer (LB), 
boiled for 10 minutes and spinned down. To identify the molecular weight a Precision plus 
Protein ™ Dual Colour Standards (Bio Rad) marker was used. Proteins were separated using 
an electrical current to the gel (90 mA) for 3/4 hours.  
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3.6.3 Immunoblotting 
 In our experimental system, after electrophoresis, proteins were transferred to 
nitrocellulose membranes (0.2 µm pore size; Whatman) for 18 hours at 200 mA and then 
visualized with specific antibodies. The nitrocellulose membranes were hydrated with 1× 
TBS for 10 minutes and incubated with a Ponceau S Solution (Sigma Aldrich) for 5 min, 
followed by a wash with deionized water to make the protein bands clearly visible. The 
membranes were scanned in a GS-800 calibrated imaging densitometer (Bio-Rad) and then 
washed with 1x TBS-T for complete removal of the Ponceau S staining. The Ponceau S 
staining is applied to assess successful transference of proteins to the membrane. 
 The nitrocellulose membranes were blocked to prevent non-specific binding of 
primary antibodies93 with 5% BSA/1x TBS-T for 3/4 hours and further incubated with 
primary antibodies. The incubations with anti-TRF2 (mouse), anti-RAP1 (mouse) and anti-
γ-H2AX (mouse) were performed overnight. The incubations with the anti-LAP1 (rabbit) 
were carried out for 4 hours. After the incubation with primary antibodies, the nitrocellulose 
membranes were incubated with anti-mouse/rabbit horseradish peroxidase conjugated 
secondary antibodies for 2 hours. After 3 washes with 1x TBS-T the membranes were 
incubated for 1 min with enhanced chemiluminescence (ECL) detection kit, for 5 minutes 
with Luminata™ Crescendo Western HRP Substrate (Millipore) or for 4 minutes with 
ECL™ Select WB detection reagent (GE Healthcare) in ChemiDoc™ Touch Imaging 
System (Bio-Rad). ECL™ is a light non-radioactive method to detect immobilized antigens 
that are directly or indirectly conjugated with horseradish peroxidase (HRP)-labelled 
antibodies.  
  
3.6.4 Immunocytochemistry assay 
 The immunocytochemistry (ICC) is a technique that through protein-antibody 
interactions allows the visualization of the location of a specify protein and their subcellular 
localization94.  
 Initially, the cells were washed with 1x PBS and then fixed with 4% 
paraformaldehyde (PFA) for 20 minutes to stabilize and preserve cells as close to life-like 
as possible. Afterwards, the cells were washed trice with 1x PBS and permeabilized with the 
addition of a detergent, 0.2 % Triton in PBS for 10 minutes, which solubilizes cellular 
membranes without destroying protein-protein interactions and allows that the antibodies 
  
 
33 
 
and other probes penetrate inside. Then, the cells were blocked with 3% BSA/1x PBS for 1 
hour to block non-specific binding sites.  
 Following blocking, the samples were incubated with the proper specific primary 
antibody and fluorochrome-labeled secondary antibodies diluted, both in 1x PBS/ 3% BSA, 
for 2 and 1 hours respectively, as described in table 1 and 2. The cells were washed thrice 
with 1x PBS following permeabilization, between antibody incubation periods and after 
incubation with the secondary antibodies. Then, the samples were mounted on a microscope 
slide with DAPI-containing VECTASHIELD® Mounting media (Vector Laboratories). The 
microscope slides were visualized in a fluorescent microscope, using the Olympus IX-81 
(Olympus, Optical Co. GmbH) motorized inverted microscope equipped with a PlanApo/ 
1.40 oil immersion objective lens. Photographs were obtained with a digital CCD 
monochrome camera F-view II (Soft Imaging System). 
 
Table 4. Summary of the excitation and emission wavelengths of the secondary antibodies. 
Fluorophores 
Excitation maximum 
(nm) 
Emission maximum 
(nm) 
Observed 
color 
Alexa Fluor 488 495 519 Green 
Alexa Fluor 594 590 617 Red 
 
 
3.6.5 Co-immunoprecipitation assay  
 The SH-SY5Y cells were washed with cold 1x PBS and then gently scrapped off the 
culture plate with in 1 mL of CHAPS lysis buffer (50 mM Tris-HCl pH=8, 120 mM NaCl, 
4% CHAPS) that contains protease inhibitors (1 mM PMSF, 10 mM Benzamidine, 2 µM 
Leupeptin, 1.5 µM Aprotinin, 5 µM Pepstatin A). Then, the lysates were mass-normalized 
using BCA assay and were precleared with 10 μl Protein G Dynabeads for 1 hour at 4°C 
with agitation.    
In a new microtube, 40 µl of Protein G Dynabeads were added to 400 µl of washing 
solution (3% BSA in PBS) containing the primary antibody, respectively LAP1, TRF2 or 
RAP1 at respective dilutions, as described in table 1 for 1 hour at 4ºC with agitation. The 
Protein G Dynabeads bind to the Fc region of primary antibodies, the immune complex is 
precipitated on a beaded support to which an antibody-binding protein is immobilized.  
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After 1 hour, the samples were added to the microtube that contains the primary 
antibody and Protein G Dynabeads and incubated overnight at 4ºC with agitation. Then, the 
supernatant was removed and the beads were washed with 400 µl of 1x PBS for 10 min at 
4º C with agitation. The microtube is placed on a magnet, where the beads migrate to the 
side of the tube facing the magnet and allowed for easy removal of the supernatant. After 
the last wash, the supernatant was fully discarded and the beads were resuspended in 100 µl 
of 1x LB and boiled for 10 min at 90º C for disruption of the Protein G Dynabeads from the 
antibody protein complexes. Finally, the Protein G Dynabeads were magnetically removed 
and the immunoprecipitates were resolved in a 7.5% SDS-PAGE followed by 
immunoblotting. 
 
3.7 Quantification and statistical analysis 
 
 Ponceau-stained membranes were scanned using GS-800 imaging densitometer 
(Bio-Rad) and protein bands were quantified through the Image Lab™ software (Bio-Rad). 
This software quantifies band intensity and correlates it to proteins levels. All the data was 
corrected for the loading control (Ponceau-S) and the fold increase was calculated in relation 
to the control (0 µM) and expressed as mean ± SEM. The statistical analysis was performed 
using one-way ANOVA and t-test with the GraphPad prism 6 software. The one-way 
ANOVA test was performed within each concentration of H202 and time point, followed by 
the Dunnets test (for comparison of data with control values)95. The t-test was performed to 
compare the means between two groups (control and 80µM of H202) at 12 hours
95. 
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4. Results   
4.1 Identification of TRF2 as novel LAP1 interactor by Co-
Immunoprecipitation  
Protein-protein interactions are involved in all cellular processes. When a protein- 
protein interaction is identified, it is essential to validate the interaction and establish the 
physiological function in a biological system. Co-immunoprecipitation is a technique crucial 
to validate interactions between proteins and it is based on the formation of antigen-antibody 
complexes96. A recent study from our group reported that LAP1 can stabilize interactions 
with two proteins of shelterin complex, namely TRF2 and RAP145. To identify TRF2 and 
RAP1 as novel LAP1 interactors, co-immunoprecipitation assays were performed in SH-
SY5Y cells. Initially, different acrylamide percentages were tested to separate the gel around 
75-50 kDa and to avoid the intense signal from the immunoglobulin heavy chains (50 kDa) 
which might overlap with the LAP1C (56 kDa) band signal. SH-SY5Y cells were 
immunoprecipitated with anti-LAP1 antibody, anti-TRF2 and anti-RAP1 antibodies (Figure 
14-16). Cells lysates and co-immunoprecipitates were separated by 7.5% SDS-PAGE and 
then transferred to a nitrocellulose membranes. Then, these nitrocellulose membranes were 
immunoblotted with anti-LAP1, anti-TRF2 and anti-RAP1 antibodies and developed by 
ECL (Figure 14-16).  
 
Figure 14. Validation of LAP1 interaction with TRF2 and RAP1 by Co-Immunoprecipitation. 
Immunoblot analysis of SH-SY5Y cells immunoprecipated with anti-LAP1 and immunoblotted with anti-
LAP1, anti-TRF2 and anti-RAP1. Dynabeads (Cnt Dynabeads) alone and Dynabeads plus Rabbit IgG (Cnt IgG 
Rb) were used as negative controls. 
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 As shown in figure 14, LAP1 was efficiently immunoprecipitated using the anti-
LAP1 antibody, since LAP1C isoform was only detected in the immunoprecipitation 
condition. The TRF2 antibody detects two bands around 65 and 69 kDa, these polypeptides 
share highly homologous motifs and are collectively termed TRF297,98. Therefore, using the 
anti-TRF2 antibody we were able to detect two bands of 65 and 69 kDa indicating that TRF2 
was successfully co-immunoprecipitated with LAP1 and the two proteins interact (Figure 14). 
However, RAP1 was not co-immunoprecipitated with LAP1 antibody (Figure 14).  The 
immunoprecipitations were also carried out using both TRF2 and RAP1 antibodies.  The 
results of co-immunoprecipitation using the TRF2 antibody are presented in Figure 15. 
 
Figure 15. Validation of TRF2 interaction with LAP1 and RAP1 by Co-Immunoprecipitation. 
Immunoblot analysis of SH-SY5Y cells immunoprecipated with anti-TRF2 and immunoblotted with anti-
TRF2, anti-LAP1 and anti-RAP1. Dynabeads (Cnt Dynabeads) and Dynabeads plus Mouse IgG (Cnt IgG Ms) 
were used as negative controls. 
 As shown in figure 15, TRF2 was successfully immunoprecipitated, since TRF2 was 
immunoprecipitated only when the TRF2 antibody was used and not with the negative controls 
(Figure 15). Further, LAP1C was also detected when the co-immunoprecipitation performed 
with TRF2 antibody (Figure 15). However, LAP1C seems to bind non-specifically to negative 
controls, namely Dynabeads and Dynabeads plus Mouse IgG (Figure 15). In addition, when 
co-immunoprecipitation of TRF2 was immunoblotted with anti-RAP1 antibody, it was 
showed that TRF2 interacts with Rap1, as previously  reported (Figure 15)81. The results of 
co-immunoprecipitation using the Rap1 antibody are presented in Figure 16. 
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Figure 16. Validation of RAP1 interaction with TRF2 and LAP1 by Co-Immunoprecipitation. 
Immunoblot analysis of SH-SY5Y cells immunoprecipated with anti-RAP1 and immunoblotted with anti-
RAP1, anti-LAP1 and anti-TRF2. Dynabeads (Cnt Dynabeads) and Dynabeads plus Mouse IgG (Cnt IgG Ms) 
were used as negative controls. 
 RAP1 was successfully immunoprecipitated, since RAP1 was immunoprecipitated 
only when RAP1 antibody was used and not with negative controls (Figure 16). The LAP1C 
also was detected in co-immunoprecipitation of RAP1 (Figure 16), however, as referred 
previously, LAP1 seems to bind non-specifically to negative controls, namely Dynabeads and 
Dynabeads plus Mouse IgG (Figure 16). In addition, RAP1 also interacts with TRF2, as 
indicated by our previous results  (Figure 15) and as described in literature81. 
 
4.2 Identification of TRF2 as novel LAP1 interactor by liquid 
chromatography-mass spectrometry 
 A different approach based on HPLC-MS technique (High performance liquid 
chromatography-mass spectrometry) was used in order to confirm that both TRF2 and RAP1 
are in fact novel LAP1 binding proteins. SH-SY5Y cells were incubated with different 
concentrations of OA (Okadaic Acid), namely 0, 0.25 and 500 nM. The 0.25 nM 
concentration of OA inhibits PP2A (Protein phosphatase 2A) and 500 nM of OA inhibits 
both PP2A and PP137. In order to identify the enrichment of TRF2 and RAP1 peptides in 
each condition, cells were co-immunoprecipitated using the LAP1 primary antibody. The 
samples were loaded on a 10 % SDS-PAGE followed by Coomassie blue colloidal staining. 
The bands that corresponds to LAP1C (56 kDa) and LAP1B (68 kDa) were excised. 
Following careful excision, the bands were tryptically digested and analyzed in a Nano-
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HPLC system online coupled to a Q Exactive mass spectrometer (Thermo Fisher Scientific, 
Germany) (Table 5). Of note, this experience was performed by a previous member of our 
group, Mariana Santos, to validate new isoform of LAP1 (LAP1C). The results were further 
analyzed in order to detect peptides corresponding to  TRF2 and RAP1 peptides41. 
 
Table 5. TRF2 and RAP1 peptides identified by HPLC-MS analysis. The SH-SY5Y cells were 
treated with different concentrations of OA (Okadaic Acid) and co-immunoprecipitated with LAP1 antibody. 
These were loaded in 10% SDS-PAGE and stained with Coomassie blue colloidal staining. The bands 
corresponding to LAP1B (68 kDa) and LAP1C (56 kDa) were excised and analyzed by HPLC- MS. The 
number of peptides of TRF2 and RAP1 are identified in each condition.  
 
Overall, for all conditions analyzed, only two TRF2 peptides were identified when 
LAP1 was immunoprecipitated, namely with 500 nM of OA (Table 5). Of note is that, at this 
condition both PP1 and PP2A were inhibited. Therefore, it seems that TRF2 interacts with 
LAP1 when it reaches its phosphorylation stage (inhibition of PP1 and PP2A). RAP1 
peptides were not found in any of the co-immunoprecipitation conditions. 
 
Peptides 
LAP1B (68 kDa) +LAP1C (56 kDa) 
 
IP OA 0nM 
 
IP OA 0.25 Nm 
 
IP OA 500 nM 
 
 
 
 
 
 
TRF2  
QPAPGPVEKPPREPAR    
TLSGAQDSEAAFAK    
TEFTLTEAVVESSR    
DLVLPTQALPASPALK    
WTVEESEWVK    
DIMQALLVRPLGK    
NLAHPVIQNFSYETFQQK    
NDLLNIIR    
FYFHEALR    
NDLLNIIR   X 
FLESHLDDAEPYLLTMAK    
DLVLPTQALPASPALK   X 
 
 
 
 
RAP1 
SSLTQHSWQSLKDR    
SPSSVTGNALWK    
FNLDLSTVTQAFLK    
IAFTDADDVAILTYVK    
NSGELEATSAFLASGQR    
EIGILTTNK    
KPIDYTILDDIGHGVK    
IIAPANLERPVR    
TLEPVRPPVVPNDYVPSPTR    
SSLTQHSWQSLKDR    
Number of peptides 0 0 2 
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4.3 Potential role of LAP1:TRF2 during DNA damage 
4.3.1 Optimization of HeLa cells growth curve upon H202 exposure 
 LAP1 is a transmembrane protein of the NE which is phosphorylated by ATM during 
mitosis40. ATM is a kinase involved in DNA damage response and it is activated by oxidative 
stress induced by Hydrogen Peroxide (H202)
57,90. In telomeres, TRF2 interacts with a set of 
key proteins involved in the DNA damage response, namely ATM, MRN complex, Ku, 
WRN and BLM, together cooperating in functions of DNA repair87. In this study, TRF2 was 
identified as a novel LAP1 interactor. TRF2 protects mammalian telomeres from the 
activation of DNA damage checkpoints83 and it interacts with DSBs in response to DNA 
damage induced by laser microbeam irradiation84,87. To understand the LAP1 physiological 
roles it is important the identification of novel LAP1 binding proteins and their cellular 
functions. Therefore, one of the aims of this thesis was investigate the role of LAP1 and 
TRF2 during DNA damage induced by oxidative stress. To induce DNA damage, several 
H202 concentrations were tested in order to induce DNA damage. HeLa cells were seeded 
with a cell density of 0.5×105 cells per well and the plates cultured for 16 hours at 37ºC in a 
humidified chamber with 5% CO2. The cells were treated with different concentrations of 
H202, namely 0, 100, 200, 400, 800 and 1000 µM and collected at several specific time points 
(0, 6, 12 and 24 hours). The cell viability was measured using the Trypan blue assay (Figure 
17). The concentrations of H202 and the times points were chosen according to a published 
study65. 
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Figure 17. Effects of H202 on the cell growth of HeLa cells. Cells were treated with the indicated 
concentrations of H202 for 0h, 6h, 12h and 24 hours.  
 All concentrations of H202 tested lead to a reduction of cell viability, except in the 
untreated control (0 µM). At 100 µM of H202, there was a reduction in the number of viable 
cells until the 12 hours’ time-point, and remain constant there after (Figure 17). 
Concentrations between 200 and 1000 µM of H202 significantly induce cell death and growth 
inhibition (Figure 17). Therefore, we decided to test lower concentrations of H202. The 
experiment above was repeated and DNA damage was induced with novel concentrations of 
H202, namely 0, 10, 20, 40, 80 and 160 µM. In each time point (0, 6, 12, 18 and 24 hours) 
cell viability was measured with the Trypan blue assay. 
 
Figure 18. Effects of H202 on the cell growth of HeLa cells. Cells were treated with the indicated 
concentrations of H202 for 0, 6, 12, 18 and 24 hours.  
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 Apparently, no reduction of cell viability with the lowest H202 (10 µM) concentration 
was observed (Figure 18). With 20 µM of H202, the number of viable cells decreases until 
the 12 hours’ time point but afterwards the cells seem to recuperate (Figure 18). At 40 µM, 
the cell curve maintains a linear behavior, whereas 80 and 100 µM of H202 lead to a reduction 
of the viable cell number count until the 24 hours’ time point (Figure 18). After these 
analysis, we verified that lower concentrations induce a limited reduction in the number of 
viable cells but higher concentrations lead to a dramatic reduction in the number of viable 
cells at all times points. After analysis of these results, we decided that the ideal H202 
concentrations for subsequent studies are from 0, 20, 40 and 80 µM. The incubation periods 
selected were 0, 6 and 12 hours. 
 
4.3.2 Effects of H2O2 on the cell growth in HeLa cells 
To evaluate the physiological role of LAP1 and TRF2 during DNA damage induced 
by H202, the number of seeding cells was optimized, after optimization of H202 concentrations 
and respective times points. We also decide to increase the number of cells seeded per well, 
since we consider that with the concentration of 0.5×105 cells per well, the cells were not 
with the adequate confluency upon 16 hours. 12-well plates were seeded with 1.6×105 cells 
and cultured for 16 hours at 37ºC in a humidified 5% CO2 chamber. After 16 hours, different 
concentrations of H202 (0, 20, 40 and 80 µM) were added to the cells. The cells were 
collected at the different times points and the number of viable cells was counted through 
the Trypan blue assay. The cell viability results were similar to the previous experiment 
(Figure 19), and therefore we decide to work with this concentration in future experiments.  
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Figure 19. Effects of H2O2 on the cell growth of HeLa cells. Cells were treated with the indicated 
concentrations of H202 for 0, 6 and 12 hours. Data are presented as mean ± SEM of at least six independent 
experiments (n=6). *p< 0.05 statistic symbol: * for comparisons between 0µM and 80µM of H202 at 12 hours, 
by using one-way ANOVA followed by the Dunnets test. 
 
 The number of viable cells in all concentrations tested apparently increase at the 6 
hours’ time point (Figure 19). The number of viable cells increases at 12 hours’ time point 
with both 20 µM and 40 µM of H202 concentrations, but the number of viable cells with the 
highest H202 concentration (80 µM) significantly decrease at 12 hours’ time point (p< 0.05, 
by one-way ANOVA followed by the Dunnets test) (Figure 19 and Appendix 1A). These 
results showed an average of six experiments (n=6). 
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4.3.3 Percentage of apoptotic cells 
As visualized in the previous experiments, the number of viable cells varies along 
the curve according the H202 concentration (Figure 19). To assess the effect of H202 in the 
apoptotic mechanism we decide to measure the percentage of apoptotic nucleus induced by 
different H202 concentrations. HeLa cells were seeded and incubated at 37ºC with 5% CO2 
for 16 hours. After 16 hours, cells were incubated with different concentrations of H202 (20, 
40 and 80 µM of H202). The control condition has no addition of H202. In each time point (0, 
6 and 12 hours) the cells were fixed and the samples were mounted on a microscope slide 
with DAPI-containing VECTASHIELD® Mounting media.  The number of apoptotic 
nucleus was counted in each condition (Figure 20-22).  
 
 
 Figure 20. Representative DAPI staining of apoptotic nucleus in different concentrations of H202 
at 0 hours. The images represent apoptotic nucleus with different concentrations of H202 at 0 hours. The arrows 
(↖) represent the apoptotic nucleus found in each condition.  
0 Hours
0 µM of H202 20 µM of H202
40 µM of H202 80 µM of H202
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Figure 21. Representative DAPI staining of apoptotic nucleus in different concentrations of H202 
at 6 hours. The images represent apoptotic nucleus with different concentrations of H202 at 6 hours. The arrows 
(↖) represent the apoptotic nucleus found in each condition. 
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Figure 22. Representative DAPI staining of apoptotic nucleus in different concentrations of H202 
at 12 hours. The images represent apoptotic nucleus with different concentrations of H202 at 12 hours. The 
arrows (↖) represent the apoptotic nucleus found in each condition. 
To calculate the percentage of apoptotic nucleus, we considered the three types of 
apoptotic nucleus that are described in literature91, namely chromatin condensation, nuclear 
fragmentation and nuclear condensation. The counting in each condition was always 
compared with controls. In all conditions, nucleus with chromatin condensation and nuclear 
fragmentation were not found. Overall, apoptotic nucleus presented a reduction in nuclear 
size and a structure similar to pyknosis (nuclear condensation) (Figure 20-22). The 
percentage of apoptotic cells was calculated for each condition (Figure 23).  
12 Hours
0 µM of H202 20 µM of H202
40 µM of H202 80 µM of H202
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Figure 23. Percentage of apoptotic nucleus. Cells were treated with the indicated concentrations of 
H202 for 0h, 6h and 12 hours. Results present the percentage of apoptotic nucleus calculated in each condition. 
Data are presented as the mean ±SEM of at least three independent experiments (n=3). #/* p< 0.05 statistic 
symbols: # for comparisons between 0µM and 20µM, 0µM and 40µM and 0µM and 80µM of H202 at 6 hours, 
using one-way ANOVA followed by the Dunnets test, * for comparisons between 0µM and 80µM of H202 at 
12 hours, using one-way ANOVA followed by the Dunnets test. 
 The percentage of apoptotic nucleus at the 0 hours’ time point is essentially similar, 
around 8% (Figure 23). At the 6 hours’ time point, there is a significantly increase to 10-
11% of apoptotic cells in each condition (20, 40 and 80 µM) (p< 0.05, by one-way ANOVA 
followed by the Dunnets test) (Figure 23 and Appendix 1B). At the 12 hours’ time point, it 
was also observed an increase of apoptotic cells in each condition, being with 80 µM of H202 
registered the highest percentage of apoptotic cells, around 13% (Figure 23). After this 
analysis, we conclude that there a significantly increase of percentage of apoptotic nucleus 
with 80µM of H202 at 12 hours (p< 0.05, by one-way ANOVA followed by the Dunnets test) 
(Figure 23 and Appendix 1B). Next, we decided to evaluate the intracellular levels of both 
TRF2 and LAP1 and consequently the role of LAP1:TRF2 complex in the same conditions. 
Simultaneously, a marker of DNA damage was also monitored in the same conditions. 
4.3.4 Detection of cellular DNA damage induced by H202 
H2AX is phosphorylated by ATM on its Ser139 site. The phosphorylation of H2AX 
(γ-H2AX) at the Ser139 is considered a hallmark of DNA damage, namely for DSBs64. To 
further investigate the DNA damage induced by H202, HeLa cells were incubated with 
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different concentrations of H202, namely 0, 20, 40 and 80µM.  The cells were harvested in 
different times points (0, 6, 12 hours) and further analyzed by SDS-PAGE and 
immunoblotting using anti-γ-H2AX Ser139 antibody. The results are presented in figure 24. 
 
Figure 24. γ-H2AX expression in HeLa cells upon H202 exposure. Cells were treated with the 
indicated concentrations of H202 for 0, 6 and 12 hours. Cell lysates were collected and analyzed by 
immunoblotting with anti-γ-H2AX Ser139 antibody. A- Immunoblot of cell lysates probed with anti-mouse 
monoclonal γ-H2AX Ser139. B- Quantification of γ-H2AX levels in HeLa cells upon H202 exposure. Data are 
presented as the mean ± SEM of at least three independent experiments (n=3).  
The phosphorylation of H2AX (γ-H2AX) increase in the presence of 20 µM of H202 
condition, mainly at 6 hours (Figure 24). Concentrations with 40 µM and 80 µM of H202 not 
seems changes in the levels of γ-H2AX (Figure 24). 
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4.3.5 Evaluate the expression levels of the LAP1:TRF2 complex 
during DNA damage  
TRF2 is a protein associated with DNA damage response and telomere signaling83,87 
and it was identified in this study as a novel LAP1 interactor (as shown in the previous 
sections), therefore, the physiological function of this complex should be presumed. The 
expression levels of both LAP1 and TRF2 were evaluated during DNA damage response 
induced by H202 exposure. HeLa cells were incubated with different concentrations of H202, 
namely 0, 20, 40 and 80µM. The cells were harvested at different times points (0, 6, 12 
hours) and further analyzed by SDS-PAGE and immunoblotting using anti-LAP1 and anti-
TRF2 antibodies. The results are presented in figures 25 and 26. 
 
Figure 25. LAP1 expression in HeLa cells upon H202 exposure. Cells were treated with the 
indicated concentrations of H202 for 0, 6 and 12 hours. Cell lysates were collected and analyzed by 
immunoblotting with anti-LAP1 antibody. A- Immunoblot of cell lysates probed with anti-rabbit polyclonal 
LAP1. B- Quantification of LAP1 (LAP1B+LAP1C) levels in HeLa cells upon H202 exposure. Data are 
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presented as the mean ± SEM of at least five independent experiments (n=5). */# p< 0.05 statistic symbols: * 
for comparisons between 0µM and 80µM of H202 at 12 hours, using one-way ANOVA followed by the Dunnets 
test, # for comparisons between 0 and 12 hours’ time points with 20 µM of H202, using one-way ANOVA 
followed by the Dunnets test. 
 
 When the cells were incubated with reduced concentrations of H202 (20µM), the 
expression levels of LAP1 significantly decrease at 12 hours’ time point, comparatively to 
the control (0 hours) (p< 0.05, by one-way ANOVA followed by the Dunnets test) (Figure 
25 and Appendix 1C). The effect observed in 40 µM is similar to 20 µM, but the reduction 
was not significantly (Figure 25). The 80 µM of H202 condition appears to induce a 
significantly decreasing of total LAP1 at 12 hours (p<0,05, by one-way ANOVA followed 
by the Dunnets test) (Figure 25 and Appendix 1C).  
 
Figure 26. TRF2 expression in HeLa cells upon H202 exposure. Cells were treated with the 
indicated concentrations of H202 for 0, 6 and 12 hours. Cell lysates were collected and analyzed by 
immunoblotting with anti-TRF2 antibody. A- Immunoblot of cell lysates probed with anti-mouse monoclonal 
TRF2. B- Quantification of TRF2 levels in HeLa cells upon H202 exposure. Data are presented as the mean ± 
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SEM of at least three independent experiments (n=3). */# p< 0.05 statistic symbols: * for comparisons between 
0µM and 20µM, 0µM and 40µM of H202 at 6 hours, by using one-way ANOVA followed by the Dunnets test, 
# for comparisons between 0µM and 20µM, 0µM and 40µM of H202 at 12 hours, by using one-way ANOVA 
followed by the Dunnets test. 
 
Both 20 and 40 µM of H202 concentrations induce a significant reduction of TRF2 
expression in all time points (p<0.05 one-way ANOVA followed Dunnets test) (Figure 26 
and Appendix 1C). With the highest H202 concentration (80 µM) the expression levels of 
TRF2 decreases at 6 hours’ time point and apparently increases at 12 hours’ time point 
(Figure 26).  
4.3.6 Evaluation of the subcellular distribution of LAP1 and TRF2 
during DNA damage 
To further address the physiological relevance of LAP1:TRF2 complex during DNA 
damage, the subcellular distribution and co-localization of both proteins in HeLa cells was 
analyzed. HeLa cells were plated in 12-well plates at cell density of 1.6×105 cells per well 
and cultured for 16 hours at 37ºC in a humidified 5% CO2 chamber. After 16 hours, the cells 
were incubated with 80 µM of H202 for 12 hours, alongside with control condition. After that 
period, the cells were fixed and proceeded for ICC. To monitor the presence of DSBs 
induced by H202 indirect immunofluorescence visualization of γ-H2AX was used. This 
histone forms discrete foci in chromatin containing DSB87. LAP1 was stained with anti-
LAP1 antibody (labelled with green Alexa 488), TRF2 was stained with anti-TRF2 antibody 
(labelled with red Alexa 594) and γ-H2AX was stained with anti-γ-H2AX Ser139 antibody 
(labelled with red Alexa 594) (Figure 27 and 28). The samples were mounted on a 
microscope slide with DAPI-containing VECTASHIELD® Mounting media.  Fluorescence 
micrographs were taken by using a fluorescent microscope, Olympus IX-81 (Olympus, 
Optical Co. GmbH).  
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Figure 27. Subcellular distribution of LAP1 and γ-H2AX in HeLa cells. Cells were treated with 
80 µM of H202. The control condition also was prepared. At 12 hours, the cells were fixed. LAP1 was stained 
with anti-LAP1 antibody (labelled with green Alexa 488) and γ-H2AX was stained with anti-γ-H2AX Ser139 
antibody (labelled with red Alexa 594). The nucleus was stained with DAPI. A) Co-localization of LAP1 with 
γ-H2AX with 0 and 80 µM of H202. The co-localization of LAP1, γ-H2AX and DAPI staining can be observed 
in the merged figures (arrows). B) Quantification of γ-H2AX foci at control and 80 µM of H202. Data are 
presented as the mean ±SEM of at least three independent experiments (n=3). * p< 0.05 statistic symbols: *for 
comparisons between 0µM and 80µM of H202 at 12 hours, using t-test. 
As previously described, LAP1 is a NE protein responsible by NE maintenance40. 
This protein is located mainly in the NE and in some points in the nucleus itself, as shown 
in Figure 27A. γ-H2AX was found mainly in the nucleus. This histone forms discrete foci in 
chromatin and each foci represents DSBs87 (Figure 27A). Co-localization of LAP1 with γ-
H2AX in two conditions (0 and 80µM of H202 at 12 hours) was observed at several 
subnuclear structures and at specific points near of the NE (Figure 27A).  
To detect DNA damage and repair in situ in individual cells for each condition, we 
decided count the number of the γ-H2AX foci per cell (Figure 27B). These quantitative 
results allowed the detection of γ-H2AX in chromatin (red spots in Figure 27B), these spots 
indicated DSBs99. In the control, ±60 γ-H2AX foci per cell were counted while in the 80 µM 
condition ±90 γ-H2AX foci were found (Figure 27B). The concentration of 80 µM of H202 
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at 12 hours leads to a significantly increase of γ-H2AX foci per cell, when compared with 
the control (p< 0.05, by t-test) (Figure 27B and Appendix 1D).  
After this analysis, we decided to co-localize LAP1 with TRF2 in the same 
conditions. TRF2 is a novel LAP1 interacting protein (as showed above) and in response to 
DNA damage it migrates to specific sites of DNA damage, namely DSBs and co-localizes 
with DSBs87.  
 
Figure 28. Subcellular distribution of LAP1 and TRF2 in HeLa cells. Cells were treated with 80 
µM of H202. The control condition also was prepared. At 12 hours, the cells were fixed. LAP1 was stained with 
anti-LAP1 antibody (labelled with green Alexa 488) and TRF2 was stained with anti-TRF2 antibody (labelled 
with red Alexa 594). The nucleus was stained with DAPI. A) Control co-localization of LAP1 with TRF2. B) 
Co-localization of LAP1 with TRF2 with 80 µM of H202. The co-localization of LAP1, TRF2 and DAPI 
staining can be observed in the merged figures (arrows).  
LAP1 is located mainly in the NE, as previously described (Figure 28). TRF2 is 
enriched mainly in the nucleus of HeLa cells in two conditions but some immunoreactivity 
in the cytoplasm was also observed (Figure 28). The co-localization between LAP1 and 
TRF2 was observed mostly at several points near of the NE in the two conditions (Figure 
28).  
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4.4 Potential role of LAP1:TRF2 in cell cycle progression 
LAP1 seem to play a fundamental role during mitosis, since it maintains the NE 
structure and it is involved in cell cycle progression. In interphasic cells, LAP1 was found 
associated to lamins and chromosomes40. TRF2 is a protein located in chromosome ends and 
it is essential for the protection of all chromosomes in all steps of cell cycle100. Both proteins 
appear to be associated with cell cycle progression. Therefore, we decided to evaluate the 
LAP1:TRF2 complex during cell cycle progression in HeLa cells. To address this purpose, 
we plated HeLa cells at cell density of 1.6×105 cells per well. The plate was incubated at 
37ºC with 5% CO2 for 16 hours. Upon this period, the cells were fixed. LAP1 was stained 
with anti-LAP1 antibody (labelled with green Alexa 488) and TRF2 was stained with anti-
TRF2 antibody (labelled with red Alexa 594) (Figure 29). The samples were mounted on a 
microscope slide with DAPI-containing VECTASHIELD® Mounting media.  Fluorescence 
micrographs were taken by using a fluorescent microscope, Olympus IX-81 (Olympus, 
Optical Co. GmbH).  
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Figure 29. Subcellular distribution of LAP1 and TRF2 in HeLa cells during cell cycle 
progression. LAP1 was stained with anti-LAP1 antibody (labelled with green Alexa 488) and TRF2 was 
stained with anti-TRF2 antibody (labelled with red Alexa 594). The nucleus was stained with DAPI. The co-
localization of LAP1, TRF2 and DAPI staining during cell cycle progression can be observed in the merged 
figures.  
 58 
 
 During interphase, LAP1 is localized at the nuclear periphery in accordance with its 
location in the INM and TRF2 is found mainly in the nucleus (Figure 29). The co-localization 
of these two proteins in this phase occurs in some points near of NE (Figure 29). In the initial 
phase of mitosis (prophase), LAP1 begins to disperse with the NE and TRF2 is dispersed 
from the nucleus to the nuclear periphery (Figure 29). In this phase, the co-localization 
between these two proteins occurs mainly in NE (Figure 29). In prometaphase, an 
intermediary phase between prophase and metaphase, LAP1 does not appear to have NE 
localization and TRF2 localizes mainly around the nucleus (Figure 29). At metaphase, LAP1 
appears to be distributed through the cell in a punctuated pattern, excluding the chromosomal 
area while TRF2 is also found around the chromosomal area (Figure 29). In anaphase, LAP1 
appears to have the same localization as in metaphase while that TRF2 appears to be found 
around of chromosomal area where it co-localizes with LAP1 in cytoplasm (Figure 29). At 
initial stages of telophase, LAP1 is found around condensated chromosomes and TRF2 is 
present in the condensated chromosomal areas. Both proteins co-localize in the nuclear 
periphery (Figure 29). In late telophase, LAP1 is found in the NE and TRF2 locates mainly 
in the nuclear area but also in same points of the NE (Figure 29). At the end of mitosis, the 
two proteins co-localize in the nuclear periphery (Figure 29). 
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5. Discussion  
LAP1 is an ubiquitously expressed protein encoded by the TOR1AIP1 gene and 
located at the INM26. LAP1 was identified using a monoclonal antibody generated against 
lamina-enriched fractions of rat liver nuclei. This antibody recognizes three members of 
LAP1, namely LAP1A, LAP1B and LAP1C that are a result of alternative splicing of the 
TOR1AIP1 gene26,36,37. However, in humans only 2 isoforms are known, LAP1B and 
LAP1C38. The exact physiological function of LAP1 is unknown, LAP1 has been associated 
to several functions through its binding to several proteins. Several LAP1 functions were 
described, such as, nuclear architecture maintenance and chromatin regulation in association 
to lamins, regulation of cell cycle progression by binding to PP1, regulation of torsinA 
ATPase activity, NE localization of torsinA and NE dynamics by binding to torsinA and also 
in NE integrity and skeletal muscle maintenance by the interaction with emerin39. Recently, 
a study from our group allowed for the identification of several novel putative LAP1 
functionally associated proteins, namely TRF2, RAP1, RIF1, ATM, MAD2L1 and 
MAD2L1BP. Some of these proteins are involved in DNA damage response and telomere 
signaling45.  
 
5.1 Identification of TRF2 as a novel LAP1 interactor 
Telomeres are protective caps responsible for the protection of chromosomal ends in 
order to maintain genomic integrity69. The structure of telomeres and its signaling functions 
are regulated by a complex termed the shelterin complex101. This complex comprises six 
proteins, among these are TRF2 and RAP1. These two proteins appear to be novel putative 
LAP1 interactors45. In order to assess this interaction co-immunoprecipitation assays were 
performed. This technique is used to validate protein interactions by formation of antigen-
antibody complexes96. Several co-immunoprecipitations using specific antibodies directed 
against LAP1, TRF2 and RAP1 were performed. LAP1 binds to TRF2, confirming that 
TRF2 as a novel LAP1 interactor (Figure 14). Furthermore, we also established that RAP1 
does not co-immunoprecipitates with LAP1. As expected, Rap1 was able to co-
immunoprecipitates with TRF2 and the same result was obtained when RAP1 antibody was 
used to co-immunoprecipitation. This is in agreement with previous results where the 
interaction was established81 (Figure 15 and 16). LAP1C was co-immunoprecipitated with 
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TRF2 and RAP1 (Figure 15 and 16). However, this isoform was also detected in the negative 
controls (Figure 15 and 16). LAP1C appears to bind non-specifically to Dynabeads and 
Dynabeads plus Mouse IgG, therefore these results are inconclusive. Future experiments will 
be necessary to increase the number of samples, prolong the washing steps, change the 
Dynabeads used, or decrease incubation time (Dynabeads and sample) during the Co-
Immunoprecipitation assay. Overall co-immunoprecipitations, LAP1B was not detected, 
since this isoform is less abundant in both human cell lines and in tissues, as previously 
reported38. In the future, to detect this isoform (LAP1B) will be necessary to increase the 
amount of protein used for each co-immunoprecipitation experiment. Given that the results 
with LAP1 antibody were very clear we are very confident that TRF2 and not RAP1 is a 
novel LAP1 binding protein. To further pursued this idea co-immunoprecipitations of LAP1 
were performed in cells incubated with different concentrations of OA (0, 0.25 and 500 nM). 
The samples were separated by SDS-PAGE and the bands correspondent to LAP1C (56 kDa) 
and LAP1B (68 kDa) were excised and analyzed in a Nano-HPLC coupled to a Q Exactive 
mass spectrometer. Essentially, we analyzed the presence of peptides correspondent to TRF2 
and RAP1 peptides in each condition. Only two TRF2 peptides were identified in co-
immunoprecipitation of LAP1, on cells incubated with 500 nM of OA (Table 5). The OA is 
an inhibitor of the serine and/ or threonine phosphatases. The 500 nM of OA inhibits both 
PP1 and PP2A102. Protein-protein interactions are regulated by mechanisms of protein 
phosphorylation, which involve protein kinases and phosphatases. PP2A and PP1 are 
serine/threonine phosphatase responsible for the dephosphorylation of more than one-third 
of proteins in eukaryotic cells. Recently, a study from our group established that LAP1 is a 
novel PP1 substrate and that PP1 dephosphorylates LAP1 on Ser306 and Ser31037,38. When 
PP1 and PP2A are inhibited, LAP1 becomes phosphorylated and apparently binds more to 
TRF2. However, to confirm this results phosphorylation assays should be performed.  
In conclusion, TRF2 is a novel LAP1 interactor, however further experiments will 
be necessary to confirm this result.  
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5.2 Potential role of LAP1:TRF2 during DNA damage 
To understand the physiological role of LAP1 it is crucial to validate novel LAP1 
binding proteins and determine their dual cellular functions. TRF2 is a shelterin component 
required to prevent mammalian telomeres from activating DNA damage checkpoints83. This 
protein has been reported to anchor the shelterin complex to double-stranded telomeric 
DNA103 and is crucial in the end-protection of chromosomes by suppression of ATM 
activation, namely by inhibition of autophosphorylation of ATM kinase on Ser198179,83. 
TRF2 interacts with RAP1 (as showed in the results of this thesis, Figure 15) forming a 
complex77. This complex is associated with a set of key proteins involved in DNA damage 
responses, namely ATM, MRN complex, Ku, DNA-PKcs, WRN, BLM77,86. In fact, the 
involvement of telomeres in cellular responses to DNA damage has been explored83. TRF2 
has been described as a protein that associates the telomeres to proteins that are involved in 
DSBs repair84,87. The non-telomeric role of TRF2 in response to DNA damage remains to be 
determined, but it is actually known that this protein is phosphorylated by ATM and interacts 
with DSBs, migrating to these sites in response to DNA damage84,87. LAP1 appears to also 
be associated to ATM kinase. During mitosis, LAP1 is regulated by mechanisms of 
phosphorylation that involve the action of several kinases that regulate the cell cycle, among 
them is ATM40. Both LAP1 and TRF2 seem to have in common the binding to ATM kinase 
as a regulatory mechanism. To further investigate the potential relevance of the LAP1:TRF2 
complex, we decided to evaluate the putative role of this complex in response to stimulation 
of ATM kinase activity upon DNA damage. ATM activation is caused by DSBs. The DSBs 
are originated by multiple factors, including oxidative stress58,60. When the cells are exposed 
to these agents, DSBs are originate and recognized by a complex, termed the MRN complex. 
The MRN complex regulates the activation of ATM which phosphorylates and recruits 
downstream effectors, namely BRAC1, 53BP1, H2AX, p53, CHK2, FANCD2, SMC1 and 
BLM162. Oxidative stress causes different types of DNA damage, among these are DSBs. 
The activation of ATM by H202 has been well documented, however, the capacity of H202 
to induce DNA damage through others mechanisms has been controversial104,105. H202 is a 
ROS involved in ATM activation, H2AX phosphorylation and DSBs generation91. To study 
the concentrations and time points of H202 treatment that would induce DNA damage, 
optimization of HeLa cells growth upon H202 exposition was performed (Figure 17 and 18). 
The 0, 20, 40 and 80 µM of H202 concentrations were chosen and 0, 6 and 12 hours were the 
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times points selected to investigate the role of the LAP1:TRF2 complex during DNA damage 
(Figure 19). At 12 hours, all the concentrations of H202 present variability on number of 
viable cells (Figure 19). Additionally, in this time point with 80 µM of H202 a significant 
reduction of cell viability cell was observed (p< 0.05, by one-way ANOVA followed by the 
Dunnets test) (Figure 19 and Appendix 1A). Therefore, to assess the effect of H202 in the 
apoptotic mechanism, the percentage of apoptotic nucleus in each condition was measured 
(Figure 20-22). The highest percentage of apoptotic nucleus was measure in 80µM of H202 
at 12 hours (around 13%) (p< 0.05, by one-way ANOVA followed by the Dunnets test) 
(Figure 23 and Appendix 1B). To confirm these results, it will be necessary to perform a 
new assay to detect DNA fragmentation, for example, by using the TUNEL assay. 
DNA damage induced by H202 was monitored through western blot analysis of γ-
H2AX (Figure 24). γ-H2AX is considered a hallmark of DNA damage, namely DSBs64. In 
response to the formation of DSBs, this histone is phosphorylated in Ser139 by ATM64,99. In 
this study, the γ-H2AX Ser139 increases with concentration of 20µM of H202, at 6 hours. 
However, the results of γ-H2AX are not statistically significant. To confirm DNA damage 
induced by H202 it will be necessary to monitor DNA damage through others assays, such as 
the Comet assay. After detection of DNA damage induced by H202, the expression of LAP1 
and TRF2 was evaluated in same conditions. The expression of LAP1 was significantly 
decrease in 20µM and 80µM at 12 hours comparatively to the control (p< 0.05, by one-way 
ANOVA followed by the Dunnets test) (Figure 25 and Appendix 1C). Interestingly, the 
expression of TRF2 is also significantly reduced at 6 and 12 hours with 20 and 40µM of 
H202, relative to control (p< 0.05, by one-way ANOVA followed by the Dunnets test) (Figure 
26 and Appendix 1C). Previous studies have shown that TRF2 association with DSB is 
temporary, TRF2 associates with DSB induced by a DNA intercalator (laser microbeam 
irradiation) within 2 seconds of irradiation. TRF2 decreases exponentially at sequential time 
points87. These findings suggest that TRF2 is expressed at initial stages of DSB formation 
and LAP1 seems to have an expression profile similar to TRF2.  
In conclusion, lower concentrations of H202 leads to DSBs, increasing the 
phosphorylation status of H2AX on Ser139. In response to DSBs formation, the expression 
of LAP1 and TRF2 decreases significantly.  
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5.3 Subcellular distribution of LAP1 and the novel interacting protein 
TRF2 during DNA damage 
 We established that LAP1:TRF2 complex is formed in vitro and we assume that both 
proteins might participate in cellular functions. Therefore, it is important to determine the 
subcellular distribution of these proteins and also the specific structures that they are 
associated. To evaluate the localization of LAP1 and γ-H2AX complex during DNA 
damage, co-localization of LAP1 with γ-H2AX in HeLa cells (0 and 80µM H202 during 12 
hours) was performed (Figure 27A). LAP1 locates mainly in the NE and in some points in 
the nucleus itself, as previously reported40 (Figure 27A). The immunostaining of γ-H2AX in 
cells is marked with discrete foci in chromatin containing DSBs, as previously reported87 
(Figure 27A). In control (12 hours) ±60 foci per cell were counted, while in the 80µM 
condition (12 hours) the registered number of foci per cell was significantly superior around 
±90 (p< 0.05, t-test) (Figure 27B and Appendix 1D). In response to 80µM of H202, LAP1 
co-localizes with γ-H2AX in the DSBs and in specific points near to the NE (Figure 27A). 
The same was observed in the control condition (Figure 27A). However, to confirm these 
results it will be necessary to increase the number of experiments (n) for each condition. 
After co-localization of LAP1 and γ-H2AX, the co-localization of the LAP1 with TRF2 was 
performed under the same conditions. TRF2 exhibited an enriched localization to the nucleus 
(Figure 28). In response to DNA damage, TRF2 co-localizes with DSBs as previously 
reported87. Co-localization between these two proteins was observed mostly at specific 
points near of the NE (Figure 28). However, to verify these results it will be necessary to 
increase the number of experiments (n) for each condition. In these studies, the 
concentrations and the time points were chosen before optimization of γ-H2AX antibody for 
western-blot, as a future perspective it will be necessary to repeat this assay analyzing new 
concentrations and time points that in fact correspond to DNA damage, namely 20µM of 
H202 at 6 hours, since in this concentration H2AX phosphorylation reaches a peak.   
In conclusion, LAP1 co-localizes with γ-H2AX in some points of the NE and nucleus, 
in response to DNA damage. Additionally, LAP1 co-localizes with TRF2 in the nuclear 
periphery. However, to strengthen these conclusions it will be necessary to repeat this 
experiment in future, with a new concentration of H202, namely 20µM of H202 at 6 hours. 
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5.4 Role of LAP1:TRF2 complex in cell cycle progression 
In eukaryotes, the chromosomes are enclosed by a double membrane which separates 
the nucleus from the cytoplasm, the NE. This physical barrier separates the chromosomes 
from cytoplasmic structures106. During cell division, the NE suffers an extensive 
transformation in its architecture to ensure that segregated DNA is enclosed in a single cell 
nucleus in each daughter cell107. In the beginning of mitosis, the NE is completely 
disassembled and it reassembles again at the end of mitosis. The NE breakdown is a dynamic 
mechanism that allows chromosomes to access the microtubule spindle and involves a set of 
processes that include disassembly of NPCs, depolymerization of lamins and spreading of 
the NE soluble components and INM proteins to the cytoplasm and ER. The reassembly of 
the NE in the end of mitosis is marked by the concentration of the INM proteins and lamins 
on the decondensing chromatin, lamin polymerization and NPC assembly40,107. LAP1 is an 
integral protein of the INM crucial to the maintenance of the NE structure and cell cycle 
progression40. TRF2 is a ubiquitous protein present in more than 100 copies per chromosome 
end and it is crucial for protection of all chromosomes in all steps of cell cycle78,100. Both 
proteins appear to be associated with cell cycle progression. In order to evaluate the 
localization of the LAP1:TRF2 complex during cell cycle progression, co-localization 
between LAP1 and TRF2, in HeLa cells, was performed. During interphase, LAP1 is located 
in the nuclear periphery and in some points inside the nucleus where it associates to lamins 
and chromossomes40 while TRF2 co-localizes with telomeres in interphasic nuclei100. In 
interphasic HeLa cells, LAP1 was also found in the NE and internal nuclear structures, while 
TRF2 was localized mainly to the nucleus (Figure 29). The co-localization between these 
two proteins during interphase was found in some points of the NE (Figure 29). At the end 
of interphase, the activation of mitotic kinases triggers the entry into prophase. This phase 
is characterized by a series of events: i) chromatin condensation, ii) formation of 
microtubules around the centrosomes, iii) chromosome separation, iv) retraction of INM 
proteins into ER, v) NPCs and lamins disassembly and vi) NE breakdown107. The breakdown 
of the NE allows the chromosomes to access the microtubule spindle for correct chromosome 
segregation40. During the prophase, TRF2 disperses away from the nucleus108 and LAP1 
localizes to the ER membranes, concomitant with nuclear lamins depolymerization109. In 
this study, LAP1 it is completely dispersed from the NE in prometaphase, as described in 
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literature40 (Figure 29). TRF2 disperses away from the nucleus accumulating in nuclear 
periphery during prophase and prometaphase, as described in literature (Figure 29). During 
prophase and prometaphase, the co-localization between these proteins occurred essentially 
in the nuclear periphery (Figure 29). In metaphase, most of soluble NE components are 
located in the cytoplasm and the INM proteins concentrate in the tubular mitotic ER107. 
During this phase, LAP1 presents a punctuated pattern in the nucleus excluding 
chromosomal area40 and TRF2 is found dispersed away, from condensed chromosomes108. 
The findings are in agreement with the literature, since LAP1 appears to be excluded from 
chromosomal area and TRF2 is dispersed from condensed chromosomes, locating mainly 
around them (Figure 29). The co-localization between both proteins occurs essentially 
throughout the cytoplasm (Figure 29). In the last steps of mitosis, the NE starts to reform its 
structure around chromatin. In anaphase, the chromatin begins to decondensate, the INM 
proteins remain dispersed into tubular mitotic ER and the NPCs reassemble107. In this phase, 
LAP1 occupies the same localization as in metaphase (Figure 29)40. The localization of 
TRF2 is unknown in this phase but it appears to be present around decondensating 
chromosomes while it co-localizes with LAP1 around nucleus (Figure 29). Throughout 
telophase, the NE reformation occurs and the INM proteins bind to DNA again while NPCs 
and lamins reassembly is achieved107. In the last steps of mitosis, LAP1 is found encircling 
the chromosomes even where they still not fully decondensed, this association to telomeres 
contributes to the NE reassembly through lamins which target chromosomes and anchor 
chromatin to the NE40,110. At an early stage of telophase, TRF2 re-entries into areas of 
decondensing chromosomes and returns to its initial position in the nucleus (nucleolus) at 
late telophase108. In this study, LAP1 surrounds the decondensating chromosomes in 
telophase while completely encircling the chromosomes in late telophase (Figure 29). In 
both phases, TRF2 localizes mainly in the nucleus (Figure 29). The co-localization between 
these two proteins occurs is some points of the NE, mainly at late telophase (Figure 29).  
During mitosis, LAP1 co-localizes with acetylated α-tubulin in the mitotic spindle 
and γ-tubulin (organization of microtubules) in mitotic cells40. The role and association of 
TRF2 with these structures remains unknown. LAP1 is crucial for cycle progression, 
specifically in centrosome positioning. The knockdown of LAP1 causes a reduction of 
number of the mitotic cells, abnormal morphology of interphasic cells, alteration of 
acetylated α-tubulin distribution, formation of aberrant mitotic spindle and mitotic exit, 
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increasing of distance between the centrosomes and NE and reduction of γ-tubulin levels 
which results in microtubule instability40.  
 In conclusion, LAP1 and TRF2 appear to be two proteins functionally associated to 
cell cycle progression. At the initial phases of the mitosis, when the NE breakdown occurs, 
TRF2 is recruited to the nuclear periphery and disperses around the condensed 
chromosomes. This dispersion could be related to the fact that chromosomes need to access 
the microtubule mitotic spindle. At end of mitosis, when the NE is reassembled TRF2 gets 
back to its initial position where it associates with decondensed chromatin. In all phases of 
mitosis, LAP1 and TRF2 appear to present a similar subcellular distribution, co-localizing 
in some points of NE in the initial and final steps of mitosis and in the nuclear periphery in 
the intermediate steps of mitosis. LAP1 and TRF2 are found in the nuclear periphery when 
the NE is disassembled and located to specific points of the NE when it is reassembled again. 
These results confirm that TRF2 can be a good candidate for the attachment of telomeres to 
the NE in somatic cells111.  As future perspectives, it will be necessary to perform new 
immunofluorescence assays with the detection of other proteins involved in of cell cycle 
progression, namely, acetylated α-tubulin and γ-tubulin. Additionally, it would be interesting 
to analyze if the localization of TRF2 changes during cell cycle progression after the 
knockdown of LAP1. However, to confirm the role of this protein complex during mitosis it 
will be necessary increase the number of experiments (n) already performed. Finally, it 
would also be interesting to accomplish the LAP1 knockdown experiment in order to 
evaluate the TRF2 expression profile.
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6. Concluding remarks 
LAP1 is an integral membrane protein located in the INM. To date, its functions 
remain poorly understood, but several crucial cellular functions have been associated to 
LAP1 due to its interactions with some proteins, including lamins, torsinA, emerin and 
PP1. Several novel putative LAP1 interactors are emerging. In this study, TRF2 was 
identified as a novel LAP1 interactor. The work included in this thesis provides new 
physical and functional important associations of LAP1 to its newly described interactor 
TRF2, in response to DNA damage and in cell cycle progression. 
In short, the co-immunoprecipitation and HPLC-MS assays allowed the 
identification of a novel LAP1 interactor, TRF2. TRF2 is a protein involved in telomere 
signaling, DNA damage response and cell cycle progression. In response to DNA damage, 
the expression of this complex is significantly reduced. During this, LAP1 possibly co-
localizes with γ-H2AX in the DSBs and in some points of the NE and co-localizes with 
TRF2 in the nuclear periphery. This complex is also associated with cell cycle progression. 
When the NE is reassembled, the complex is located mainly in specific regions of the NE, 
evidencing that TRF2 allows the attachment of chromosomes to the NE membrane in 
somatic cells. Several experiments are still needed to performed and further explored these 
results, but we believe that this work will help advance the knowledge of the biological and 
molecular functions of the LAP1:TRF2 complex, particularly, in DNA damage response 
and cell cycle progression. 
 
In conclusion, this work results in: 
 Validation of TRF2 as a novel LAP1 interactor; 
 Unravelling the potential role of LAP1 and TRF2 in response to DNA 
damage; 
 Determining the subcellular distribution of LAP1 and its novel interacting 
protein TRF2, during DNA damage; 
 Unravelling the potential role of LAP1:TRF2 complex during progression of 
cell cycle. 
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Future perspectives: 
 To confirm the effect of H202 in the induction of apoptosis by the TUNEL assay; 
 To verify the detection of DNA damage induced by H202 by the Comet assay; 
 As LAP1 is phosphorylated by ATM during mitosis, it will be necessary evaluate 
the phosphorylation status of LAP1 in response to DNA damage using Phostag 
SDS PAGE method or manufacturing an antibody for phosphorylated LAP1; 
 To further investigate if LAP1 and TRF2 interact in response to DNA damage, it 
will be interesting to perform co-immunoprecipitations of LAP1 and TRF2 
incubated with H202 (20 µM during 6 hours) and immunoblotted with anti-TRF2 
and anti-LAP1 respectively; 
 To detect subcellular distribution of this complex in response to DNA damage, it 
will be necessary to perform new immunofluorescence assays with new 
concentrations of H202, namely 20 µM of H202 during 6 hours; 
 To confirm the association of this complex in response to DNA damage, it will be 
interesting to induce DNA damage by other methods, namely using Etoposide;  
 To accomplish a complete study of the complex formed between LAP1 and TRF2 
during progression of cell cycle it will be necessary to perform new 
immunofluorescence assays with detection of other proteins involved in 
progression of cell cycle, for example, acetylated α- tubulin and γ-tubulin; 
 To confirm the results obtained from immunofluorescence assays it will be 
necessary to increase the number of experiences (n) and take photos with confocal 
microscopy to thoroughly quantify the percentage of co-localizations between 
both proteins; 
 It will be interesting to perform LAP1 knockdown, in order to investigate the 
localization status of TRF2 during cell cycle progression with 
immunofluorescence assays with TRF2 antibody; 
 Lastly, the LAP1 knockdown experiment would also be interesting to identify 
possible repercussions on the DNA damage response. 
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Appendix 1 
 
 
Statistical analysis 
 
 
A. Effects of H2O2 on the cell growth in HeLa cells 
 
One-way ANOVA  p-value 
Multiple comparisons test-Dunnets  
0 µM vs 80 µM (12 hours) * 
 
B. Percentage of apoptotic cells  
 
One-way ANOVA  p-value 
Multiple comparisons test-Dunnets  
0 µM vs 20 µM (6 hours) # 
0 µM vs 40 µM (6 hours) # 
0 µM vs 80 µM (6 hours) # 
0 µM vs 80 µM (12 hours) * 
C. Evaluate the expression levels of the LAP1:TRF2 complex during DNA 
damage 
 
I. Expression levels of LAP1 
 
One-way ANOVA  p-value 
Multiple comparisons test-Dunnets  
0 µM vs 80 µM (12 hours) * 
20 µM (0 hours vs 12 hours) # 
 
II. Expression levels of TRF2 
 
One-way ANOVA  p-value 
Multiple comparisons test-Dunnets  
   0 µM vs 20 µM (6 hours) * 
0 µM vs 40 µM (6 hours) * 
0 µM vs 20 µM (12 hours) # 
0 µM vs 40 µM (12 hours) # 
 
D. Evaluation of the subcellular distribution of LAP1 and TRF2 during DNA 
damage 
 
t-test  p-value 
0 µM vs 80 µM (12 hours) * 
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Appendix 2 
 
Culture media and Solutions 
 
I. Cell culture Solutions  
 
 PBS (1x) 
For a final volume of 500 mL, dissolve one pack of BupH Modified Dulbecco’s Phosphate 
Buffered Saline Pack (Pierce) in deionized H2O. Final composition: 
 8 mM Sodium Phosphate 
 2 mM Potassium Phosphate 
 140 mM Sodium Chloride 
 10 mM Potassium Chloride 
Sterilize by filtering through a 0.2 μm filter and store at 4°C. 
 
 10% FBS MEM: F12 (1:1) 
 4.805 g MEM 
 5.315 g F12 
 1.5 g NaHCO3 
 0.055 g Sodium Pyruvate 
 10 mL Streptomycin/Penicillin/Amphotericin solution 
 100 mL 10% FBS 
 2.5 mL L-glutamine (200 mM stock solution) 
Dissolve in deionized H2O. Adjust the pH to 7.2-7.3. Adjust the volume to 1000 mL with 
deionized H2O. 
 
 10% FBS DMEM 
-13.4 g DMEM 
-3.7 g NaHCO3 
- 10 mL Streptomycin/Penicillin/Amphotericin solution (AAs) 
- 100 mL 10% FBS 
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Dissolve in deionized H2O. Adjust the pH to 7.2-7.3. Adjust the volume to 
1000 mL with deionized H2O. 
 
II. Western Blot Solutions 
 LGB (lower gel buffer) (4x) 
To 900 mL of deionized H2O add: 
 181.65 g of Tris 
 4 g of SDS 
Mix until the solutes have dissolved. Adjust pH to 8.9 and adjust the volume to 1 L with 
deionized H2O. 
 
 UGB (Upper gel buffer) (4x) 
To 900 mL of deionized H2O add: 
 75.69 g of Tris 
Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 1 L with 
deionized H2O. 
 
 10% APS (ammonium persulfate) 
In 10 mL of deionized H2O dissolve 1 g of APS. Note: prepare fresh before use. 
 
 10% SDS (sodium dodecilsulfate) 
In 10 mL of deionized H2O dissolve 1 g of SDS. 
 
 Loading Gel Buffer (4x) 
 2.5 mL 1M Tris solution (pH 6.8) 2.5 mL (250 mM) 
 0.8 g SDS (8%) 
 4 mL Glicerol (40%) 
 2 mL β-mercaptoethanol (2%) 
 1 mg Bromofenol blue (0.01%) 
Adjust the volume to 10 mL with deionized H2O. Store in darkness at room temperature. 
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 1 M Tris (pH 6.8) solution 
To 150 mL of deionized H2O add: 
 30.3 g Tris base 
Adjust the pH to 6.8 and adjust the final volume to 250 mL with deionized H2O. 
 
 10x Running Buffer 
 30.3 g Tris (250 mM) 
 144.2 g Glycine (2.5 M) 
 10 g SDS (1%) 
Dissolve in deionized H2O, adjust the pH to 8.3 and adjust the volume to 1L. 
 
 Stacking and resolving gel 
Components Running gel 
(7.5 %) 
Running gel 
(5%) 
Running gel  
(20 %) 
Stacking gel 
(3.5%) 
Water 16.71 mL 9.29 mL 3.67 mL 3.3 mL 
40% 
Acrylamide: 
Bis 
Acrylamide 
(29:1) 
 
5.63 mL 
 
1.875 mL 
 
7.5 mL 
 
0.6 mL 
4x LGB 7.5 mL 3.75 mL 3.75 mL -------------------
- 
5x UGB -------------------
- 
-------------------
- 
-------------------
- 
1.0 mL 
10% SDS -------------------
- 
-------------------
- 
-------------------
- 
50 µL 
10% APS 150 µL 75 µL 75 µL 50 µL 
TEMED 15 µL 7.5 µL 7.5 µL 5 µL 
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 Transfer Buffer (1x) 
 3.03 g Tris (25 mM) 
 14.41 g Glycine (192 mM) 
Mix until solutes dissolution. Adjust the pH to 8.3 with HCl and adjust the volume to 800 
mL with deionized H2O. Just prior to use add 200 mL of methanol (20%). 
 
 10x TBS (Tris buffered saline) 
 12.11 g Tris (10 mM) 
 87.66 g NaCl (150 mM) 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 l with deionized H2O. 
 
 10x TBST (TBS+Tween) 
 12.11 g Tris (10 mM) 
 87.66 g NaCl (150 mM) 
 10 mL Tween-20 (0.01%) 
Adjust the pH to 8.0 with HCl and adjust the volume to 1 L with deionized H2O. 
 
III. Immunofluorescence Solutions 
 
 4% Paraformaldehyde 
For a final volume of 100 mL, add 4 g of paraformaldehyde to 25 mL deionized H2O. 
Dissolve by heating the mixture at 58°C while stirring. Add 1-2 drops of 1 M NaOH 
to clarify the solution and filter through a 0.2 μM filter. Add 50 mL of 2x PBS and 
adjust the volume to 100 mL with deionized H2O. 
 
IV. H202 treatment 
 
 10 mM H202 (stock solution) 
Hydrogen peroxide (98% purity) from Acros Organic was dissolved in deionized 
water to produce a 10 Mm stock solution. 
 
